Search:
(CSV files for researchmap) [PDF manual]

Research Activity

Field of Study

Pharmacology

Subject of Study

Renal Pharmacology, Cardiovascular Pharmacology (Renal Circulation, Nitric Oxide, Oxidative Stress, MAP Kinase, Nitrite)

Book / Paper

Book:

1.Toshiaki Tamaki :
私と高血圧,
SENTAN IGAKU-SHA, Sep. 2017.
2.Yasumasa Ikeda and Toshiaki Tamaki :
Annual Review2015腎臓---腎疾患と鉄代謝異常---,
株式会社 中外医学社, Jan. 2015.
3.Licht Miyamoto, 山根 萌, 冨田 洋輔, Keisuke Ishizawa, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
ヒト腎糸球体内皮細胞における亜硝酸塩によるAMPK-eNOS活性化経路の検討,
TOKYO IGAKUSHA, Oct. 2014.
4.Yasumasa Ikeda, 田島 壮一郎, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
腎とフリーラジカル第11集,
TOKYO IGAKUSHA, Tokyo, Jan. 2013.
5.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Shoko Fujii, Jumpei Taniguchi, Yuki Izawa-Ishizawa, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
腎とフリーラジカル第11集,
TOKYO IGAKUSHA, Tokyo, Jan. 2013.
6.Koichiro Tsuchiya, Keisuke Ishizawa, Licht Miyamoto, Yuya Horinouchi, Yasumasa Ikeda, Yoshitaka Kihira, Shuhei Tomita and Toshiaki Tamaki :
腎とフリーラジカル第11集,
TOKYO IGAKUSHA, Tokyo, Jan. 2013.
7.Keisuke Ishizawa, Toshiaki Tamaki and 他 :
疾患モデルの作製と利用-循環器疾患,
LIFE-SCIENCE INFORMATION CENTER, Tokyo, Aug. 2010.
8.田島 壮一郎, Koichiro Tsuchiya, 濱本 磨以, 久住 祥子, Yuya Horinouchi, 八木 祐子, 櫻田 巧, Keisuke Ishizawa, Yasumasa Ikeda, Yoshitaka Kihira, Shuhei Tomita and Toshiaki Tamaki :
腎とフリーラジカル第10集,
TOKYO IGAKUSHA, Tokyo, Jun. 2010.
9.大西 秀樹, Koichiro Tsuchiya, 田島 壮一郎, Yuya Horinouchi, 福原 弥生, Kunihisa Yamaguchi, Keisuke Ishizawa, Shuhei Tomita and Toshiaki Tamaki :
腎とフリーラジカル第9集,
TOKYO IGAKUSHA, Tokyo, Sep. 2008.
10.Keisuke Ishizawa, 三木 恵里加, Yuki Izawa-Ishizawa, 大西 秀樹, Narantungalag Dorjsuren, 元林 有紀, Kunihisa Yamaguchi, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
腎とフリーラジカル第9集,
TOKYO IGAKUSHA, Tokyo, Sep. 2008.

Academic Paper (Judged Full Paper):

1.Yasumasa Ikeda, Akiho Satoh, Yuya Horinouchi, Hirofumi Hamano, Hiroaki Watanabe, Mizuki Imao, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Yuki Izawa-Ishizawa, Licht Miyamoto, Hirayama Tasuku, Hideko Nagasawa, Keisuke Ishizawa, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress,
The FASEB journal, Vol.33, No.8, 9551-9564, 2019.
(DOI: 10.1096/fj.201802724RR,   PubMed: 31145863)
2.Hirofumi Hamano, Marin Mitsui, Yoshito Zamami, Kenshi Takechi, Takahiro Nimura, Naoto Okada, Keijo Fukushima, Masaki Imanishi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasushi Kirino, Toshimi Nakamura, Kazuhiko Teraoka, Yasumasa Ikeda, Hiromichi Fujino, Hiroaki Yanagawa, Toshiaki Tamaki and Keisuke Ishizawa :
Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.,
Supportive Care in Cancer, Vol.27, No.3, 849-856, 2019.
(DOI: 10.1007/s00520-018-4367-y,   PubMed: 30062585)
3.Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Toya Hiroki, Nagao Tomoko, Marin Morishita, Koichi Tsuneyama, Yuya Horinouchi, Yoshitaka Kihira, Kenshi Takechi, Yasumasa Ikeda, Koichiro Tsuchiya, Masanori Yoshizumi, Toshiaki Tamaki and Keisuke Ishizawa :
Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses.,
Journal of Hypertension, Vol.37, No.1, 73-83, 2019.
(Tokushima University Institutional Repository: 113264,   DOI: 10.1097/HJH.0000000000001898,   PubMed: 30303488)
4.Masaki Imanishi, Yuki Izawa-Ishizawa, T Sakurada, Y Kohara, Yuya Horinouchi, E Sairyo, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yasumasa Ikeda, Hiromichi Fujino, M Yoshizumi, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation.,
Pharmacology, Vol.102, No.5-6, 281-286, 2018.
(DOI: 10.1159/000492577,   PubMed: 30253416,   Elsevier: Scopus)
5.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Hirofumi Hamano, Yuki Izawa-Ishizawa, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis.,
Scientific Reports, Vol.8, No.1, 2018.
(Tokushima University Institutional Repository: 112445,   DOI: 10.1038/s41598-018-29008-2,   PubMed: 30022146)
6.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease,
Nephrology, Dialysis, Transplantation, Vol.33, No.4, 586-597, 2018.
(DOI: 10.1093/ndt/gfx252,   PubMed: 28992067)
7.Wenting Xu, Licht Miyamoto, Haruna Aihara, Tomomi Yamaoka, Naonobu Tanaka, Yuki Tsuchihashi, Yasumasa Ikeda, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
Methanol extraction fraction from Citrus Sudachi peel exerts lipid reducing effects in cultured cells.,
The Journal of Medical Investigation : JMI, Vol.65, No.3.4, 225-230, 2018.
(DOI: 10.2152/jmi.65.225,   PubMed: 30282865)
8.Katsunori Tsuda, Licht Miyamoto, Shuichi Hamano, Yuri Morimoto, Yumi Kangawa, Chika Fukue, Yoko Kagawa, Yuya Horinouchi, Wenting Xu, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate.,
Biological & Pharmaceutical Bulletin, Vol.41, No.4, 555-563, 2018.
(DOI: 10.1248/bpb.b17-00855,   PubMed: 29607928)
9.Takahiro Niimura, Yoshito Zamami, Toshihiro Koyama, Yuki Izawa-Ishizawa, Masashi Miyake, Tadashi Koga, Keisaku Harada, Ayako Ohshima, Toru Imai, Yutaka Kondo, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki, Shiro Hinotsu, R Mitsunobu Kano and Keisuke Ishizawa :
Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest.,
Scientific Reports, Vol.7, No.1, 2017.
(Tokushima University Institutional Repository: 112397,   DOI: 10.1038/s41598-017-17686-3,   PubMed: 29263333)
10.Yasumasa Ikeda, Yuya Horinouchi, Hamano Hirofumi, Hirayama Tasuku, Seiji Kishi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Ken-ichi Aihara, Hideko Nagasawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice,
Scientific Reports, Vol.7, No.1, 10621, 2017.
(Tokushima University Institutional Repository: 112368,   DOI: 10.1038/s41598-017-11089-0,   PubMed: 28878231)
11.Keisuke Oshima, Yasumasa Ikeda, Yuya Horinouchi, Hiroaki Watanabe, Hirofumi Hamano, Yoshitaka Kihira, Seiji Kishi, Yuki Izawa-Ishizawa, Licht Miyamoto, Tasuku Hirayama, Hideko Nagasawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation,
Laboratory Investigation; a Journal of Technical Methods and Pathology, Vol.97, No.5, 555-566, 2017.
(DOI: 10.1038/labinvest.2017.11,   PubMed: 28263291)
12.Yutaka Fukunaga, Yuki Izawa-Ishizawa, Yuya Horinouchi, Eriko Sairyo, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Yoshiro Abe, Ichiro Hashimoto and Toshiaki Tamaki :
Topical Application of Nitrosonifedipine, a Novel Radical Scavenger, Ameliorates Ischemic Skin Flap Necrosis in a Mouse Model.,
Wound Repair and Regeneration, Vol.25, No.2, 217-223, 2017.
(DOI: 10.1111/wrr.12510,   PubMed: 28090711)
13.Masaki Imanishi, Chiba Yoichi, Tomita Noriko, Matsunaga Shinji, Nakagawa Toshitaka, Ueno Masaki, Yamamoto Kazuhiro, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-Inducible Factor-1α in Smooth Muscle Cells Protects Against Aortic Aneurysms-Brief Report.,
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol.36, No.11, 2158-2162, 2016.
(DOI: 10.1161/ATVBAHA.116.307784,   PubMed: 27562915)
14.Yasumasa Ikeda, Mizuki Imao, Akiho Satoh, Hiroaki Watanabe, Hirofumi Hamano, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway,
Journal of Trace Elements in Medicine and Biology, Vol.35, No.5, 66-76, 2016.
(DOI: 10.1016/j.jtemb.2016.01.011,   PubMed: 27049128)
15.Yasumasa Ikeda, Hirofumi Hamano, Akiho Satoh, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Bilirubin exerts pro-angiogenic effects through an Akt-eNOS-dependent pathway,
Hypertension Research, Vol.38, No.11, 733-740, 2015.
(DOI: 10.1038/hr.2015.74,   PubMed: 26134126,   Elsevier: Scopus)
16.Soichiro Tajima, Yasumasa Ikeda, Hideaki Enomoto, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice,
European Journal of Nutrition, Vol.54, No.5, 709-719, 2015.
(DOI: 10.1007/s00394-014-0749-1,   PubMed: 25096756,   Elsevier: Scopus)
17.Yoshitaka Kihira, Ariunzaya Burentogtokh, Mari Itoh, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia decreases glucagon-like peptide-1 secretion from GLUTag cell line,
Biological & Pharmaceutical Bulletin, Vol.38, No.4, 514-521, 2015.
(DOI: 10.1248/bpb.b14-00612,   PubMed: 25832631,   CiNii: 130005062264,   Elsevier: Scopus)
18.Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Licht Miyamoto, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
A Long-Term High-Fat Diet Changes Iron Distribution in Body, Increasing Iron Accumulation Specifically in the Mouse Spleen,
Journal of Nutritional Science and Vitaminology, Vol.61, No.1, 20-27, 2015.
(DOI: 10.3177/jnsv.61.20,   PubMed: 25994136,   CiNii: 40020377946,   Elsevier: Scopus)
19.Masashi Akaike, Ken-ichi Aihara, Hiroaki Yanagawa, Takashi Iwase, Sumiko Yoshida, Sato Chiho, Saijo Tomoka, Hiroaki Mikasa, Kashiwada Yoshizaki, Yoshihisa Takaishi, Koichiro Tsuchiya, Toshiaki Tamaki, Toshio Matsumoto and Masataka Sata :
Efficacy and safety of Citrus sudachi peel in obese adults:A randomized, double-blind, pilot study,
Functional Foods in Health and Disease, Vol.4, No.6, 276-284, 2014.
20.Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Masaki Ueno, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya and Toshiaki Tamaki :
Smooth muscle cell specific Hif-1 deficiency suppresses angiotensin II-induced vascular remodeling in mice,
Cardiovascular Research, Vol.102, No.3, 460-468, 2014.
(DOI: 10.1093/cvr/cvu061,   PubMed: 24623277,   Elsevier: Scopus)
21.Yuko Imamura, Shuhei Tomita, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
HIF-2α/ARNT complex regulates hair development via induction of p21Waf1/Cip1 and p27Kip1,
The FASEB journal, Vol.28, No.6, 2517-2524, 2014.
(DOI: 10.1096/fj.13-244079,   PubMed: 24599965,   Elsevier: Scopus)
22.S Hayashi, Hirotsugu Yamada, Mika Bando, Junko Hotsuchi, Takayuki Ise, Koji Yamaguchi, Takashi Iwase, Takeshi Soeki, Tetsuzo Wakatsuki, Toshiaki Tamaki and Masataka Sata :
Augmentation Index does not Reflect the Risk of Coronary Artery Disease in Elderly Patients.,
Circulation Journal, Vol.78, No.5, 1176-1182, 2014.
(DOI: 10.1253/circj.CJ-13-1422,   PubMed: 24562676,   CiNii: 130003391086,   Elsevier: Scopus)
23.Atsushi Morimoto, Shuhei Tomita, Masaki Imanishi, Go Shioi, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Mitsuru Takaku, Ichiro Hashimoto, Yasumasa Ikeda, Hideki Nakanishi and Toshiaki Tamaki :
Overexpressed HIF-2α in Endothelial Cells Promotes Vascularization and Improves Random Pattern Skin Flap Survival.,
Plastic and Reconstructive Surgery. Global Open, Vol.2, No.4, e132, 2014.
(DOI: 10.1097/GOX.0000000000000083,   PubMed: 25289325,   Elsevier: Scopus)
24.Yoshitaka Kihira, Mariko Miyake, Manami Hirata, Yoji Hoshina, Kana Kato, Hitoshi Shirakawa, Hiroshi Sakaue, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation.,
PLoS ONE, Vol.9, No.4, e93856, 2014.
(DOI: 10.1371/journal.pone.0093856,   PubMed: 24705496,   Elsevier: Scopus)
25.Yasumasa Ikeda, Iori Ozono, Soichro Tajima, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction,
PLoS ONE, Vol.9, No.2, e89355, 2014.
(DOI: 10.1371/journal.pone.0089355,   PubMed: 24586712,   Elsevier: Scopus)
26.Keisuke Ishizawa, Yuki Izawa-Ishizawa, Noriko Yamano, Maki Urushihara, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Asami Nuno, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shoji Kagami, Hiroyuki Kobori, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects,
PLoS ONE, Vol.9, No.1, e86335, 2014.
(DOI: 10.1371/journal.pone.0086335,   PubMed: 24489716,   Elsevier: Scopus)
27.Hirose Kayo, Hirose Masao, Katsuya Tanaka, Shinji Kawahito, Toshiaki Tamaki and Shuzo Oshita :
Perioperative management of severe anorexia nervosa.,
British Journal of Anaesthesia, Vol.112, No.2, 246-254, 2013.
(DOI: 10.1093/bja/aet415,   PubMed: 24366724)
28.Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Mayuko Higashida, Yuki Matsuoka, Yasushi Yoshida, Yoichiro Hirata, Mie Sakata, Mark Maxfield, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa and Shuhei Tomita :
Role of macrophage-derived Hypoxia-Inducible Factor (HIF)-1 as a mediator of vascular remodeling,
Cardiovascular Research, Vol.99, No.4, 705-715, 2013.
(DOI: 10.1093/cvr/cvt146,   PubMed: 23752975)
29.Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Dietary iron restriction inhibits progression of diabetic nephropathy in db/db mice.,
American Journal of Physiology, Renal Physiology, Vol.304, No.7, F1028-F1036, 2013.
(DOI: 10.1152/ajprenal.00473.2012,   PubMed: 23389454)
30.Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Sumiko Yoshida, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia,
Journal of Cardiovascular Pharmacology, Vol.61, No.5, 423-429, 2013.
(DOI: 10.1097/FJC.0b013e318287d526,   PubMed: 23364610)
31.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Yuki Izawa-Ishizawa, Shoko Fujii, Erika Tominaga, Teppei Tsuneishi, Yuya Horinouchi, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Ken-ichi Aihara, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects,
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.386, No.1, 29-39, 2013.
(DOI: 10.1007/s00210-012-0810-7,   PubMed: 23149861,   Elsevier: Scopus)
32.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Licht Miyamoto, Shoko Fujii, Hironori Taira, Yoshitaka Kihira, Yasumasa Ikeda, Shuichi Hamano, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells,
Pharmacology, Vol.90, No.5-6, 324-331, 2012.
(DOI: 10.1159/000343244,   PubMed: 23052181,   Elsevier: Scopus)
33.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Takashi Iwase, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya, Masataka Sata, Masashi Akaike, Shigeaki Kato, Toshio Matsumoto and Toshiaki Tamaki :
Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway,
The Journal of Biological Chemistry, Vol.287, No.41, 34256-34263, 2012.
(DOI: 10.1074/jbc.M112.353532,   PubMed: 22904320)
34.Mitsuru Takaku, Shuhei Tomita, Hirotsugu Kurobe, Yoshitaka Kihira, Atsushi Morimoto, Mayuko Higashida, Yasumasa Ikeda, Akira Ushiyama, Ichiro Hashimoto, Hideki Nakanishi and Toshiaki Tamaki :
Systemic Preconditioning by a Prolyl Hydroxylase Inhibitor Promotes Prevention of Skin Flap Necrosis via HIF-1-Induced Bone Marrow-Derived Cells.,
PLoS ONE, Vol.7, No.8, 2012.
(DOI: 10.1371/journal.pone.0042964,   PubMed: 22880134)
35.Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes,
PLoS ONE, Vol.7, No.7, e40465, 2012.
(DOI: 10.1371/journal.pone.0040465,   PubMed: 22792339,   Elsevier: Scopus)
36.Soichiro Tajima, Yasumasa Ikeda, Kaori Sawada, Noriko Yamano, Yuya Horinouchi, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice.,
American Journal of Physiology, Endocrinology and Metabolism, Vol.302, No.1, E77-86, 2012.
(DOI: 10.1152/ajpendo.00033.2011,   PubMed: 21917632)
37.Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes,
The International Journal of Biochemistry & Cell Biology, Vol.43, No.11, 1602-1611, 2011.
(DOI: 10.1016/j.biocel.2011.07.009,   PubMed: 21810481)
38.Shuhei Tomita, Yoshitaka Kihira, Masaki Imanishi, Yayoi Fukuhara, Yuko Imamura, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Pathophysiological Response to Hypoxia From the Molecular Mechanisms of Malady to Drug Discovery: Inflammatory Responses of Hypoxia-Inducible Factor 1 (HIF-1) in T Cells Observed in Development of Vascular Remodeling,
Journal of Pharmacological Sciences, Vol.115, No.4, 433-439, 2011.
(DOI: 10.1254/jphs.10R22FM,   PubMed: 21422726,   Elsevier: Scopus)
39.Keisuke Ishizawa, Masanori Yoshizumi, Yoshichika Kawai, Junji Terao, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Pharmacology in health food: Metabolism of quercetin in vivo and its protective effect against arteriosclerosis,
Journal of Pharmacological Sciences, Vol.115, No.4, 466-470, 2011.
(DOI: 10.1254/jphs.10R38FM,   PubMed: 21436601)
40.Yuya Horinouchi, Koichiro Tsuchiya, Chiaki Taoka, Soichiro Tajima, Yoshitaka Kihira, Yuko Matsuda, Kozo Shishido, Masahiro Yoshida, Shuichi Hamano, Kazuyoshi Kawazoe, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita and Toshiaki Tamaki :
Antioxidant effects of photodegradation product of nifedipine,
Chemical & Pharmaceutical Bulletin, Vol.59, No.2, 208-214, 2011.
(DOI: 10.1248/cpb.59.208,   PubMed: 21297301,   Elsevier: Scopus)
41.Takaaki Shimohata, Masayuki Nakano, Xin Lian, Tomomi Shigeyama, Hitomi Iba, Akiko Hamamoto, Masaki Yoshida, Nagakatsu Harada, Hironori Yamamoto, Masayuki Yamato, Kazuaki Mawatari, Toshiaki Tamaki, Yutaka Nakaya and Akira Takahashi :
Vibrio parahaemolyticus infection induces modulation of IL-8 secretion through dual pathway via VP1680 in Caco-2 cells.,
The Journal of Infectious Diseases, Vol.203, No.4, 537-544, 2011.
(DOI: 10.1093/infdis/jiq070,   PubMed: 21177635)
42.Yayoi Fukuhara, Koichiro Tsuchiya, Yuya Horinouchi, Soichiro Tajima, Yoshitaka Kihira, Shuichi Hamano, Kazuyoshi Kawazoe, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita and Toshiaki Tamaki :
Protective effect of photodegradation product of nifedipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells,
The Journal of Medical Investigation : JMI, Vol.58, No.1, 2, 118-126, 2011.
(Tokushima University Institutional Repository: 72667,   DOI: 10.2152/jmi.58.118,   PubMed: 21372496,   CiNii: 130004465233)
43.Yasumasa Ikeda, Soichiro Tajima, Sumiko Yoshida, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Ken-ichi Aihara, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function.,
Atherosclerosis, Vol.215, No.2, 339-347, 2011.
(DOI: 10.1016/j.atherosclerosis.2011.01.009,   PubMed: 21315355)
44.Yasumasa Ikeda, Ken-ichi Aihara, Masashi Akaike, Takashi Sato, Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yuka Ueda, Sumiko Yoshida, Hiroyuki Azuma, Kenneth Walsh, Toshiaki Tamaki, Shigeaki Kato and Toshio Matsumoto :
Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.,
Molecular Endocrinology, Vol.24, No.7, 1338-1348, 2010.
(DOI: 10.1210/me.2009-0402,   PubMed: 20501642)
45.Soichiro Tajima, Koichiro Tsuchiya, Yuya Horinouchi, Keisuke Ishizawa, Yasumasa Ikeda, Yoshitaka Kihira, Masayuki Shono, Kazuyoshi Kawazoe, Shuhei Tomita and Toshiaki Tamaki :
Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells,
Hypertension Research, Vol.33, No.7, 713-721, 2010.
(DOI: 10.1038/hr.2010.63,   PubMed: 20431588,   Elsevier: Scopus)
46.Keisuke Ishizawa, Yuki Izawa-Ishizawa, Narantungalag Dorjsuren, Erika Miki, Yoshitaka Kihira, Yasumasa Ikeda, Shuichi Hamano, Kazuyoshi Kawazoe, Kazuo Minakuchi, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner,
Nephrology, Dialysis, Transplantation, Vol.25, No.2, 364-372, 2010.
(DOI: 10.1093/ndt/gfp520,   PubMed: 19812233)
47.Koichiro Tsuchiya, Shuhei Tomita, Keisuke Ishizawa, Shinji Abe, Yasumasa Ikeda, Yoshitaka Kihira and Toshiaki Tamaki :
Dietary nitrite ameliorates renal injury in l-NAME-induced hypertensive rats,
Nitric Oxide: Biology and Chemistry, Vol.22, No.2, 98-103, 2010.
(DOI: 10.1016/j.niox.2009.12.002,   PubMed: 20005970)
48.Hirotsugu Kurobe, Masahisa Urata, Masaki Ueno, Masaaki Ueki, Shiro Ono, Yuki Izawa-Ishizawa, Yayoi Fukuhara, Yu Lei, Adiratna Mat Ripen, Tamotsu Kanbara, Ken-ichi Aihara, Keisuke Ishizawa, Masashi Akaike, Frank J. Gonzalez, Toshiaki Tamaki, Yousuke Takahama, Masanori Yoshizumi, Tetsuya Kitagawa and Shuhei Tomita :
Role of Hypoxia-Inducible Factor 1α in T Cells as a Negative Regulator in Development of Vascular Remodeling,
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol.30, No.2, 210-217, 2010.
(DOI: 10.1161/ATVBAHA.109.192666,   PubMed: 20007912)
49.Maki Urushihara, Masanori Takamatsu, Maki Shimizu, Shuji Kondo, Yukiko Kinoshita, Kenichi Suga, Akiko Kitamura, Sato Matsuura, Masanori Yoshizumi, Toshiaki Tamaki, Hiroshi Kawachi and Shoji Kagami :
ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis.,
American Journal of Physiology, Renal Physiology, Vol.298, No.1, F167-76, 2010.
(DOI: 10.1152/ajprenal.00124.2009,   PubMed: 19846573)
50.Keisuke Ishizawa, Narantungalag Dorjsuren, Yuki Izawa-Ishizawa, Rika Sugimoto, Yasumasa Ikeda, Yoshitaka Kihira, Kazuyoshi Kawazoe, Shuhei Tomita, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration,
The Journal of Endocrinology, Vol.202, No.2, 309-316, 2009.
(DOI: 10.1677/JOE-08-0469,   PubMed: 19460854)
51.Yuki Motobayashi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakiko Orino, Kunihisa Yamaguchi, Kazuyoshi Kawazoe, Shuichi Hamano, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells,
Hypertension Research, Vol.32, No.3, 188-193, 2009.
(DOI: 10.1038/hr.2008.19,   PubMed: 19262481)
52.Keisuke Ishizawa, Yuki Izawa-Ishizawa, Sachiyo Ohnishi, Yuki Motobayashi, Kazuyoshi Kawazoe, Shuichi Hamano, Koichiro Tsuchiya, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
Quercetin Glucuronide Inhibits Cell Migration and Proliferation by Platelet-Derived Growth Factor in Vascular Smooth Muscle Cells,
Journal of Pharmacological Sciences, Vol.109, No.2, 257-264, 2009.
(DOI: 10.1254/jphs.08236FP,   PubMed: 19202317)
53.Keisuke Ishizawa, Kunihisa Yamaguchi, Yuya Horinouchi, Yayoi Fukuhara, Soichiro Tajima, Shuichi Hamano, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Toward drug discovery for overcoming CKD: Development of drugs on endothelial cell protection for overcoming CKD,
Journal of Pharmacological Sciences, Vol.109, No.1, 14-19, 2009.
(DOI: 10.1254/jphs.08R08FM,   PubMed: 19151535)
54.Hideki Ohnishi, Satoshi Iwanaga, Kazuyoshi Kawazoe, Keisuke Ishizawa, Sakiko Orino, Shuhei Tomita, Koichiro Tsuchiya, Yasuhisa Kanematsu, Nagakatsu Harada, Kazuhiro Mori, Tomoko Tsuchihashi, Yasuko Ishikawa and Toshiaki Tamaki :
Effect of iron-quercetin complex on reduction of nitrite in in vitro and in vivo systems,
Journal of Agricultural and Food Chemistry, Vol.56, No.21, 10092-10098, 2008.
(DOI: 10.1021/jf801010j,   PubMed: 18831560)
55.Yasuhisa Kanematsu, Kunihisa Yamaguchi, Hideki Ohnishi, Yuki Motobayashi, Keisuke Ishizawa, Yuki Izawa, Kazuyoshi Kawazoe, Shuji Kondo, Shoji Kagami, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats,
American Journal of Physiology, Renal Physiology, Vol.295, No.5, F1457-F1462, 2008.
(DOI: 10.1152/ajprenal.00621.2007,   PubMed: 18753302)
56.Masahiro Watanabe, Takenori Yamamoto, Rei Kakuhata, Naoto Okada, Kazuaki Kajimoto, Naoshi Yamazaki, Masatoshi Kataoka, Yoshinobu Baba, Toshiaki Tamaki and Yasuo Shinohara :
Synchronized changes in transcript levels of genes activating cold exposure-induced thermogenesis in brown adipose tissue of experimental animals.,
Biochimica et Biophysica Acta (BBA) - Bioenergetics, Vol.1777, No.1, 104-112, 2008.
(DOI: 10.1016/j.bbabio.2007.10.014,   PubMed: 18036333)
57.Yuki Izawa, Masanori Yoshizumi, Keisuke Ishizawa, Yoshiko Fujita, Shuji Kondo, Shoji Kagami, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration,
Hypertension Research, Vol.30, No.11, 1107-1117, 2007.
(DOI: 10.1291/hypres.30.1107,   PubMed: 18250560)
58.Ali Nermin, Masanori Yoshizumi, Seiji Yano, Saburo Sone, Hideki Ohnishi, Keisuke Ishizawa, Yasuhisa Kanematsu, Koichiro Tsuchiya and Toshiaki Tamaki :
The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and β-catenin phosphorylation but increases their association,
Journal of Pharmacological Sciences, Vol.102, No.1, 112-120, 2006.
(DOI: 10.1254/jphs.FP0060357,   PubMed: 16974068)
59.Shinji Abe, Hideki Ohnishi, Koichiro Tsuchiya, Keisuke Ishizawa, Mayumi Torii, Yasuhisa Kanematsu, Kazuyoshi Kawazoe, Kazuo Minakuchi, Masanori Yoshizumi and Toshiaki Tamaki :
Calcium and reactive oxygen species mediated Zn2+-induced apoptosis in PC12 cells,
Journal of Pharmacological Sciences, Vol.102, No.1, 103-111, 2006.
(DOI: 10.1254/jphs.FP0060342,   PubMed: 16990703)
60.Yasuhisa Kanematsu, Koichiro Tsuchiya, Hideki Onishi, Yuki Motobayashi, Yuki Izawa, Manabu Ishihara, Keisuke Ishizawa, Shinji Abe, Kazuyoshi Kawazoe and Toshiaki Tamaki :
Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nω-nitro-L-arginine methyl ester-treated rats,
Hypertension Research, Vol.29, No.5, 369-374, 2006.
(DOI: 10.1291/hypres.29.369,   PubMed: 16832158)
61.Yoshiko Fujita, Masanori Yoshizumi, Yuki Izawa, Nermin Ali, Yasuhisa Kanematsu, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.,
Endocrinology, Vol.147, No.3, 1377-1385, 2006.
(DOI: 10.1210/en.2005-0644,   PubMed: 16322069,   Elsevier: Scopus)
62.Shuji Kondo, Maki Shimizu, Maki Urushihara, Koichiro Tsuchiya, Masanori Yoshizumi, Toshiaki Tamaki, Akira Nishiyama, Hiroshi Kawachi, Fujio Shimizu, Quinn T. Mark, Lambeth J. David and Shoji Kagami :
Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progression mesangioproliferative glomerulonephritis in the rat,
Journal of the American Society of Nephrology, Vol.17, No.3, 783-794, 2006.
(DOI: 10.1681/ASN.2005050519,   PubMed: 16467449)
63.Yoshiko Fujita, Yuki Izawa, Nermin Ali, Koichiro Tsuchiya, Shuichi Hamano, Toshiaki Tamaki and Masanori Yoshizumi :
Pramipexole protects against H2O2-induced PC12 cell death,
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.372, No.4, 257-266, 2006.
(DOI: 10.1007/s00210-005-0025-2,   PubMed: 16362428,   Elsevier: Scopus)
64.Hiroyuki Sakakibara, Kaori Ishida, Yuki Izawa, Yuko Minami, Satomi Saito, Yoshichika Kawai, Veronika Butterweck, Toshiaki Tamaki, Yutaka Nakaya and Junji Terao :
Effects of forced swimming stress on rat brain function,
The Journal of Medical Investigation : JMI, Vol.52, No.Suppl., 300-3001, 2005.
(Tokushima University Institutional Repository: 111587,   DOI: 10.2152/jmi.52.300,   PubMed: 16366521)
65.田島 壮一郎, Koichiro Tsuchiya, 大西 秀樹, Yasuhisa Kanematsu, Toshiaki Tamaki, Ronald Mason and Yoshiharu Takiguchi :
Detection of protein - derived radicals by the immunochemical technique,
Folia Pharmacologica Japonica, Vol.126, No.4, 246-249, 2005.
(DOI: 10.1254/fpj.126.246,   PubMed: 16327204)
66.Koichiro Tsuchiya, Kaori Akai, Akira Tokumura, Shinji Abe, Toshiaki Tamaki, Yoshiharu Takiguchi and Kenji Fukuzawa :
Oxygen radical photo-induced by ferric nitrilotriacetate complex,
Biochimica et Biophysica Acta (BBA) - General Subjects, Vol.1725, No.1, 111-119, 2005.
(DOI: 10.1016/j.bbagen.2005.05.001,   PubMed: 15950386)
67.Yuki Izawa, Masanori Yoshizumi, Keisuke Ishizawa, Yoshiko Fujita, Shuji Kondo, Shoji Kagami, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells,
Experimental Cell Research, Vol.308, No.2, 291-299, 2005.
(DOI: 10.1016/j.yexcr.2005.04.028,   PubMed: 15921682)
68.Keisuke Ishizawa, Yuki Izawa, Hiroyuki Ito, Chieko Miki, Kayoko Miyama, Yoshiko Fujita, Yasuhisa Kanematsu, Koichiro Tsuchiya, Toshiaki Tamaki, Akira Nishiyama and Masanori Yoshizumi :
Aldosterone stimulates vascular smooth muscle cell proliferation via big mitoten-activated protein kinase 1 activation,
Hypertension, Vol.46, No.4, 1046-1052, 2005.
(DOI: 10.1161/01.HYP.0000172622.51973.f5,   PubMed: 16087789)
69.Yasumasa Ikeda, Ken-ichi Aihara, Takashi Sato, Masashi Akaike, Masanori Yoshizumi, Yuki Suzaki, Yuki Izawa-Ishizawa, Mitsunori Fujimura, Shunji Hashizume, Midori Kato, Shusuke Yagi, Toshiaki Tamaki, Hirotaka Kawano, Takahiro Matsumoto, Hiroyuki Azuma, Shigeaki Kato and Toshio Matsumoto :
Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.,
The Journal of Biological Chemistry, Vol.280, No.33, 29661-29666, 2005.
(DOI: 10.1074/jbc.M411694200,   PubMed: 15961403)
70.Ali Nermin, Masanori Yoshizumi, Yoshiko Fujita, Yuki Izawa, Yasuhisa Kanematsu, Keisuke Ishizawa, Koichiro Tsuchiya, Seiji Yano, Saburo Sone and Toshiaki Tamaki :
A Novel Src Kinase Inhibitor, M475271, Inhibits VEGF-Induced Human Umbilical Vein Endothelial Cell Proliferation and Migration,
Journal of Pharmacological Sciences, Vol.98, No.2, 130-141, 2005.
(DOI: 10.1254/jphs.FP0040850,   PubMed: 15937404)
71.Koichiro Tsuchiya, Yasuhisa Kanematsu, Masanori Yoshizumi, Hideki Ohnishi, Kazuyoshi Kirima, Yuki Izawa, Michiyo Shikishima, Tatsuhiro Ishida, Shuji Kondo, Shoji Kagami, Yoshiharu Takiguchi and Toshiaki Tamaki :
Nitrite is an alternative source of NO in vivo,
American Journal of Physiology, Heart and Circulatory Physiology, Vol.288, No.5, H2163-H2170, 2005.
(DOI: 10.1152/ajpheart.00525.2004,   PubMed: 15626692)
72.Akira Nishiyama, Li Yao, Yuyan Fan, Moe Kyaw, Noriyuki Kataoka, Ken Hashimoto, Yukiko Nagai, Emi Nakamura, Masanori Yoshizumi, Takatomi Shokoji, Shoji Kimura, Hideyasu Kiyomoto, Katsuhiko Tsujioka, Masakazu Kohno, Toshiaki Tamaki, Fumihiko Kajiya and Youichi Abe :
Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability.,
Hypertension, Vol.45, No.4, 710-716, 2005.
(DOI: 10.1161/01.HYP.0000154681.38944.9a,   PubMed: 15699469)
73.Masumi Okamoto, Koichiro Tsuchiya, Yasuhisa Kanematsu, Yuki Izawa, Masanori Yoshizumi, Susumu Kagawa and Toshiaki Tamaki :
Nitrite-derived nitric oxide formation following ischemia-reperfusion injyury in kidney.,
American Journal of Physiology, Renal Physiology, Vol.288, No.1, 182-187, 2005.
(DOI: 10.1152/ajprenal.00036.2004,   PubMed: 15367387)
74.Koichiro Tsuchiya, Yoshiharu Takiguchi, Masumi Okamoto, Yuki Izawa, Yasuhisa Kanematsu, Masanori Yoshizumi and Toshiaki Tamaki :
Malfunction of vascular control in lifestyle-related diseases : formation of systemic hemoglobin-nitric oxide Complex(HbNO) From Dietary Nitrite,
Journal of Pharmacological Sciences, Vol.96, No.4, 395-400, 2004.
(DOI: 10.1254/jphs.FMJ04006X3,   PubMed: 15599101)
75.Kaori Akai, Koichiro Tsuchiya, Akira Tokumura, Kentaro Kogure, Satoru Ueno, Akira Shibata, Toshiaki Tamaki and Kenji Fukuzawa :
Ability of ferric nitrilotriacetate complex with three pH-dependent conformations to induce lipid peroxidation.,
Free Radical Research, Vol.38, No.9, 951-962, 2004.
(DOI: 10.1080/1071576042000261945,   PubMed: 15621713)
76.Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Yuki Izawa, Yasuhisa Kanematsu, Yoshiko Fujita, Nermin Ali, Keisuke Ishizawa, Aiko Yamauchi and Toshiaki Tamaki :
Antioxidant effects of stereoisomers of N-acetylcysteine (NAC), L-NAC and D-NAC, on angiotensin II-stimulated MAP kinase activation and vascular smooth muscle cell proliferation,
Journal of Pharmacological Sciences, Vol.95, No.4, 483-486, 2004.
(DOI: 10.1254/jphs.SC0040061,   PubMed: 15297771)
77.Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Yuki Izawa, Yasuhisa Kanematsu and Toshiaki Tamaki :
Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases,
Acta Pharmacologica Sinica, Vol.25, No.8, 977-985, 2004.
(PubMed: 15301727)
78.Keisuke Ishizawa, Masanori Yoshizumi, Koichiro Tsuchiya, Hitoshi Houchi, Kazuo Minakuchi, Yuki Izawa, Yasuhisa Kanematsu, Shoji Kagami, Masao Hirose and Toshiaki Tamaki :
Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells,
Hypertension Research, Vol.27, No.6, 433-440, 2004.
(DOI: 10.1291/hypres.27.433,   PubMed: 15253109)
79.Yuki Suzaki, Masanori Yoshizumi, Shoji Kagami, Akira Nishiyama, Yuichi Ozawa, Moe Kyaw, Yuki Izawa, Yasuhisa Kanematsu, Koichiro Tsuchiya and Toshiaki Tamaki :
BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions,
Kidney International, Vol.65, No.5, 1749-1760, 2004.
(DOI: 10.1111/j.1523-1755.2004.00576.x,   PubMed: 15086914)
80.Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Shoji Kagami, Yuki Izawa, Yoshiko Fujita, Nermin Ali, Yasuhisa Kanematsu, Kazunori Toida, Kazunori Ishimura and Toshiaki Tamaki :
Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cell via extracellur signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation,
Molecular Pharmacology, Vol.65, No.4, 832-841, 2004.
(DOI: 10.1124/mol.65.4.832,   PubMed: 15044612)
81.Akira Nishiyama, Masanori Yoshizumi, Matlubur Rahman, Hiroyuki Kobori, DaleM Seth, Akira Miyatake, Guo-Xing Zhang, Li Yao, Hirofumi Hitomi, Takatomi Shokoji, Hideyasu Kiyomoto, Shoji Kimura, Toshiaki Tamaki, Masakazu Kohno and Youichi Abe :
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats,
Kidney International, Vol.65, No.3, 972-981, 2004.
(DOI: 10.1111/j.1523-1755.2004.00476.x,   PubMed: 14871417)
82.Masanori Yoshizumi, Yoshiko Fujita, Yuki Izawa, Yuki Suzaki, Moe Kyaw, Nermin Ali, Koichiro Tsuchiya, Shoji Kagami, Seiji Yano, Saburo Sone and Toshiaki Tamaki :
Ebselen inhibits tumor necrosis factor-α-induced c-jun N-terminal kinase activation and adhesion molecule expression in endothelial cells,
Experimental Cell Research, Vol.292, No.1, 1-10, 2004.
(DOI: 10.1016/j.yexcr.2003.08.003,   PubMed: 14720501,   CiNii: 80016399784)
83.Nermin Ali, Masanori Yoshizumi, Koichiro Tsuchiya, Moe Kyaw, Yoshiko Fujita, Yuki Izawa, Shinji Abe, Yasuhisa Kanematsu, Shoji Kagami and Toshiaki Tamaki :
Ebsalen inhibits p38MAP kinase-mediated endothelial cell death by hydrogen peroxide.,
European Journal of Pharmacology, Vol.485, No.1-3, 127-135, 2004.
(DOI: 10.1016/j.ejphar.2003.11.079,   PubMed: 14757132)
84.Shinji Abe, Kazuyoshi Kirima, Koichiro Tsuchiya, Masumi Okamoto, Toyoshi Hasegawa, Hitoshi Houchi, Masanori Yoshizumi and Toshiaki Tamaki :
The reaction rate of edaravone ( 3-methyl-1-phenyl-2-pyrazolin-5-one(MCI-186) with hydroxyl radical.,
Chemical & Pharmaceutical Bulletin, Vol.52, No.2, 186-191, 2004.
(DOI: 10.1248/cpb.52.186,   PubMed: 14758002,   CiNii: 110003615531)
85.Akira Nishiyama, Masanori Yoshizumi, Hirofumi Hitomi, Shoji Kagami, Shuji Kondo, Akira Miyatake, Megumu Fukunaga, Toshiaki Tamaki, Hideyasu Kiyomoto, Masakazu Kohno, Takatomi Shokoji, Shoji Kimura and Abe Youichi :
The SOD mimetic tempol ameliorates glomerular injury and reduces MAPK activity in Dahl salt-sensitive rats.,
Journal of the American Society of Nephrology, Vol.15, No.2, 306-315, 2004.
(DOI: 10.1097/01.ASN.0000108523.02100.E0,   PubMed: 14747377)
86.Toyoshi Hasegawa, Atsushi Bando, Koichiro Tsuchiya, Shinji Abe, Masumi Okamoto, Kazuyoshi Kirima, Satoru Ueno, Masanori Yoshizumi, Hitoshi Houchi and Toshiaki Tamaki :
Enzymatic and non-enzymatic formation of reactive oxygen species from 6-anilino-5,8-quinolineequinone,
Biochimica et Biophysica Acta (BBA) - General Subjects, Vol.1670, No.1, 19-27, 2004.
(DOI: 10.1016/j.bbagen.2003.10.008,   PubMed: 14729138)
87.Koichiro Tsuchiya, Kazuyoshi Kirima, Masanori Yoshizumi and Toshiaki Tamaki :
New methods to evaluate endotherial function: Evaluation of endotherial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopy,
Journal of Pharmacological Sciences, Vol.93, No.4, 417-422, 2003.
(DOI: 10.1254/jphs.93.417,   PubMed: 14737011)
88.Kentaro Kogure, Koichiro Tsuchiya, Kazutoyo Abe, Michinori Akasu, Toshiaki Tamaki, Kenji Fukuzawa and Hiroshi Terada :
Direct radical scavenging by the bisbenzylisoquinoline alkaloid cepharanthine.,
Biochimica et Biophysica Acta (BBA) - General Subjects, Vol.1622, No.1, 1-5, 2003.
(DOI: 10.1016/S0304-4165(03)00095-3,   PubMed: 12829254)
89.Masanori Yoshizumi, Abe Jun-ichi, Koichiro Tsuchiya, Bradford C.Berk and Toshiaki Tamaki :
Stress and vascular responses: Atheroprotective effect of laminar fluid shear stress in endothelial cells: Possible role of mitogen-activated protein kinases ( Review ),
Journal of Pharmacological Sciences, Vol.91, No.3, 172-176, 2003.
(DOI: 10.1254/jphs.91.172,   PubMed: 12686737)
90.Yuichi Ozawa, Toyoshi Hasegawa, Koichiro Tsuchiya, Masanori Yoshizumi and Toshiaki Tamaki :
Effect of endothelin-1(1-31) on the renal resistance vessels.,
The Journal of Medical Investigation : JMI, Vol.50, No.1-2, 87-94, 2003.
(Tokushima University Institutional Repository: 110682,   PubMed: 12630573)
91.Kazuyoshi Kirima, Koichiro Tsuchiya, Hiroyoshi Sei, Toyoshi Hasegawa, Michiyo Shikishima, Yuki Motobayashi, Kyoji Morita, Masanori Yoshizumi and Toshiaki Tamaki :
Evaluatin of systemic blood NO dynamics by EPR Spectoscopy: HbNO as an endogenous index of NO,
American Journal of Physiology, Heart and Circulatory Physiology, Vol.285, No.2, H589-H596, 2003.
(DOI: 10.1152/ajpheart.01010.2002,   PubMed: 12663263)
92.Yuki Suzaki, Masanori Yoshizumi, Yukio Yamashita, Shinji Abe, Koichiro Tsuchiya, Yumiko Satoh, Yasuhiro Kuroda, Kazuya Horike, Masashi Kano, Yoshio Fukuta, Takashi Kitaichi, Takaki Hori, Yutaka Masuda, Tetsuya Kitagawa, Kazuo Minakuchi and Toshiaki Tamaki :
Determination of plasma concentrations of endothelin-1(1-31) and endothelin-1 in healthy subjects and patients with atherosclerosis.,
Journal of Cardiovascular Pharmacology, Vol.41, No.suppl.1, S83-S87, 2003.
(PubMed: 12688403)
93.Akiko Kitamura, Shoji Kagami, Maki Urushihara, Syuji Kondo, Masanori Yoshizumi, Toshiaki Tamaki and Yasuhiro Kuroda :
Endothelin-1 is a potent stimulator of a1b1 integrin-mediated collagen matrix remodeling by rat mesangial cells.,
Biochemical and Biophysical Research Communications, Vol.299, No.4, 555-561, 2002.
(DOI: 10.1016/S0006-291X(02)02693-1,   PubMed: 12459174)
94.Koichiro Tsuchiya, Kazuyoshi Kirima, Masanori Yoshizumi, Toshiaki Tamaki and Ronald Mason :
The role of thiol and nitrosothiol compounds in the NO-forming reactions of the iron-MGD complex.,
The Biochemical Journal, Vol.367, No.Pt 3, 771-779, 2002.
(DOI: 10.1042/BJ20020310,   PubMed: 12141947)
95.Masanori Yoshizumi, Toshiaki Kogame, Yuki Suzaki, Yoshiko Fujita, Moe Kyaw, Kazuyoshi Kirima, Keisuke Ishizawa, Koichiro Tsuchiya, Shoji Kagami and Toshiaki Tamaki :
Ebselen attenuates oxidative styress-induced apoptosis via the inhibition of the c jun N-terminal kinase and activator protein-1 signaling pathway in PC12 cells.,
British Journal of Pharmacology, Vol.136, No.7, 1023-1032, 2002.
(DOI: 10.1038/sj.bjp.0704808,   PubMed: 12145102)
96.Maki Urushihara, Shoji Kagami, Takeshi Kuhara, Toshiaki Tamaki and Yasuhiro Kuroda :
Glomerular distribution and gelatinolytic activity of natrix metalloproteinases in human glomerulonephritis.,
Nephrology, Dialysis, Transplantation, Vol.17, No.7, 1189-1196, 2002.
(DOI: 10.1093/ndt/17.7.1189,   PubMed: 12105240)
97.Masanori Yoshizumi, Koichiro Tsuchiya, Yuki Suzaki, Kazuyoshi Kirima, Moe Kyaw, Moon Jae-Hak, Junji Terao and Toshiaki Tamaki :
Quercetin Glucronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.,
Biochemical and Biophysical Research Communications, Vol.293, No.5, 1458-1465, 2002.
(DOI: 10.1016/S0006-291X(02)00407-2,   PubMed: 12054679)
98.Yuki Suzaki, Masanori Yoshizumi, Shoji Kagami, Hajime Koyama, Yutaka Taketani, Hitoshi Houchi, Koichiro Tsuchiya, Eiji Takeda and Toshiaki Tamaki :
Hydrogen Peroxide Stimulates c-Src-mediated Big Mitogen-activated Protein Kinase 1(BMK1) and the MEF2C Signaling Pathway in PC12 Cells,
The Journal of Biological Chemistry, Vol.277, No.11, 9614-9621, 2002.
(DOI: 10.1074/jbc.M111790200,   PubMed: 11782488,   CiNii: 80015264938)
99.Akiko Kitamura, Shoji Kagami, Maki Urushihara, Syuji Kondo, Masanori Yoshizumi, Toshiaki Tamaki and Yasuhiro Kuroda :
Endothelin-1 is a potent stimulator of a1b1 integrin-mediated collagen matrix remodeling by rat mesangial cells.,
Biochemical and Biophysical Research Communications, Vol.299, 555-561, 2002.
100.Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Kasuyoshi Kirima, Yuki Suzaki, Shinji Abe, Toyoshi Hasegawa and Toshiaki Tamaki :
Antioxidants inhibit endothelin-1(1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1).,
Biochemical Pharmacology, Vol.64, No.10, 1521-1531, 2002.
(DOI: 10.1016/S0006-2952(02)01349-7,   PubMed: 12417265)
101.Keisuke Ishizawa, Masanori Yoshizumi, Koichiro Tsuchiya, Eiko Takishita, Yutaka Nakaya, Kazuhiro Kishi, Yousuke Ebina, Hitoshi Houchi, Kazuo Minakuchi and Toshiaki Tamaki :
Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.,
European Journal of Pharmacology, Vol.430, No.2-3, 359-367, 2001.
(DOI: 10.1016/S0014-2999(01)01405-4,   PubMed: 11711055,   Elsevier: Scopus)
102.Masanori Yoshizumi, Koichiro Tsuchiya, Kazuyoshi Kirima, Moe Kyaw, Yuki Suzaki and Toshiaki Tamaki :
Quercetin inhibits Shc- and Phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.,
Molecular Pharmacology, Vol.60, No.4, 656-665, 2001.
(PubMed: 11562426)
103.Shoji Kagami, K Urushihara, K. Loster, W. Reutter, Toshiaki Tamaki, Masanori Yoshizumi and Yasuhiro Kuroda :
Requirement for tyrosine kinase-ERK1/2 signaling in a1b1 integrin-mediated collagen matrix remodeling by rat mesangial cells.,
Experimental Cell Research, Vol.268, No.2, 274-283, 2001.
(DOI: 10.1006/excr.2001.5279,   PubMed: 11478853,   Elsevier: Scopus)
104.Ping Cui, Kenji Tani, Hiroko Kitamura, Yuushi Okumura, Mihiro Yano, Daisuke Inui, Toshiaki Tamaki, Saburo Sone and Hiroshi Kido :
A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes,
Journal of Leukocyte Biology, Vol.70, No.2, 306-312, 2001.
(PubMed: 11493624)
105.Kazuyoshi Kirima, Koichiro Tsuchiya, Masanori Yoshizumi, Taisuke Kameda, Hitoshi Houchi, Mami Azuma and Toshiaki Tamaki :
Electron paramagnetic resonance study on free radical scavanging and/or generating activity of dopamine-4-0-sulfate.,
Chemical & Pharmaceutical Bulletin, Vol.49, 576-580, 2001.
106.Kyaw Moe, Masanori Yoshizumi, Koichiro Tsuchiya, Kazuyoshi Kirima and Toshiaki Tamaki :
Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.,
Hypertension Research, Vol.24, No.3, 251-261, 2001.
(DOI: 10.1291/hypres.24.251,   PubMed: 11409648)
107.Naoko Okishima, Masanori Yoshizumi, Koichiro Tsuchiya, Ping Cui, Hiroko Kitamura, Toshiaki Tamaki and Hiroshi Kido :
Determination of the levels of novel 31-amino acid endothelins and endothelins in human lungs.,
Life Sciences, Vol.68, No.18, 2073-2080, 2001.
108.Masanori Yoshizumi, Koichiro Tsuchiya and Toshiaki Tamaki :
Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease,
The Journal of Medical Investigation : JMI, Vol.48, No.1,2, 11-24, 2001.
(Tokushima University Institutional Repository: 29055,   PubMed: 11286012)
109.Daisuke Inui, Masanori Yoshizumi, Yuki Suzaki, Kazuyoshi Kirima, Koichiro Tsuchiya, Hitoshi Houchi, Shoji Kagami and Toshiaki Tamaki :
Effect of Endothelin-1(1-31) on p38 Mitogen-Activated Protein Kinase in Cultured Human Mesangial Cells.,
Life Sciences, Vol.68, No.6, 635-645, 2000.
(DOI: 10.1016/S0024-3205(00)00976-0,   PubMed: 11205878,   Elsevier: Scopus)
110.Yuichi Ozawa, Hitoshi Houchi, Kazuhiko Teraoka, Mami Azuma, Takehiro Kamimura, Masanori Yoshizumi, Koichiro Tsuchiya, Toshiaki Tamaki and Kazuo Minakuchi :
Long-term regulation of catecholamine formation by ouabain in cultured bovine adrenal cromaffin cells.,
Journal of Cardiovascular Pharmacology, Vol.36, No.suppl.2, S15-S18, 2000.
(DOI: 10.1097/00005344-200000006-00005,   PubMed: 11206714,   Elsevier: Scopus)
111.Masanori Yoshizumi, Shoji Kagami, Yuki Suzaki, Koichiro Tsuchiya, Hitoshi Houchi, Tetsuhiro Hisayama, Hiroyuki Fukui and Toshiaki Tamaki :
Effect of endothelin-1(1-31) on human mesangial cell proliferation,
The Japanese Journal of Pharmacology, Vol.84, No.2, 146-155, 2000.
112.Ozawa Yuichi, Masanori Yoshizumi, Yasushi Fukuta, Daisuke Inui, Koichiro Tsuchiya, Hitoshi Houchi, Toshiaki Tamaki and Kazuo Minakuchi :
Dopamine Clearance During Dopamine Infusion in Infants and Children After Cardiac Surgery,
Journal of Cardiovascular Pharmacology, Vol.34, No.Supplement 4, S85-S89, 1999.
113.Masanori Yoshizumi, Daisuke Inui, Kazuyoshi Kirima, Koichiro Tsuchiya, Hitoshi Houchi, Mami Azuma, Hiroaki Yasuoka, Hiroshi Kido and Toshiaki Tamaki :
Comparison of the effects of endothelin-1,-2 and -3(1-31) on changes in [Ca2+]i in human coronary artery smooth muscle cells.,
The Japanese Journal of Pharmacology, Vol.81, 298-304, 1999.
114.Hiroaki Yasuoka, Masanori Yoshizumi, Daisuke Inui, Naoko Okishima, Hitoshi Houchi, Kazuyoshi Kirima, Shuzo Oshita, Hiroshi Kido and Toshiaki Tamaki :
Effect of endothelin-1 (1-31) on intracellular free calcium in cultured human mesangial cells.,
Life Sciences, Vol.65, No.22, PL267--272, 1999.
115.Takabumi Umeda, Mami Azuma, Hitoshi Houchi, Toshitaka Ikehara, Fumiaki Shono, Masanori Yoshizumi, Toshiaki Tamaki and Kazuo Minakuchi :
Stimulatory effect of enkephalines on calcium efflux from bovine adrenal chromaffin cells in culture.,
Life Sciences, Vol.65, No.21, PL247-252, 1999.
116.Daisuke Inui, Masanori Yoshizumi, Okishima Naoko, Hitoshi Houchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Mechanism of endothelin-1-(1-31)-induced calcium signaling in human coronary artery smooth muscle cells.,
American Journal of Physiology, Endocrinology and Metabolism, Vol.276, No.39, E1067-E1072, 1999.
(PubMed: 10362619)
117.Hitoshi Houchi, Mami Azuma, Masanori Yoshizumi, Toshiaki Tamaki and Kazuo Minakuchi :
Possible role of bradykinin on stimulus-secretion coupling in adrenal chromaffin cells,
The Journal of Medical Investigation : JMI, Vol.46, No.1-2, 1-9, 1999.
(Tokushima University Institutional Repository: 22088,   PubMed: 10408151)
118.Koichiro Tsuchiya, Jiang Jin-Jie, Masanori Yoshizumi, Toshiaki Tamaki, Hitoshi Houchi, Kazuo Minakuchi, Kenji Fukuzawa and P.Mason Ronald :
Nitric oxide-forming reactions of the water-soluble nitric oxide spin-trapping agent, MGD.,
Free Rad. Biol. Med., Vol.27, 347-355, 1999.
119.Yuichi Ozawa, Masanori Yoshizumi, Daisuke Inui, Koichiro Tsuchiya, Hitoshi Houchi, Toshiaki Tamaki and Kazuo Minakuchi :
Plasma levels of free and sulfoconjugated catecholamines in patients with atherosclerosis.,
Biological & Pharmaceutical Bulletin, Vol.22, 657-659, 1999.
120.Hitoshi Houchi, Masanori Yoshizumi, Koichiro Tsuchiya, Masao Hirose, Tetsuya Kitagawa, Toshihida Kujime, Eiji Shimizu, Yasuharu Niwa, Kazuo Minakuchi and Toshiaki Tamaki :
Endothelin-1 stimulates sodium-dependent calcium efflux from bovine adrenal chromaffin cells in culture.,
British Journal of Pharmacology, Vol.125, No.1, 55-60, 1998.
121.Masanori Yoshizumi, Tetsuya Kitagawa, Yutaka Masuda, Kazuya Horike, Yoshihiro Ogawa, Y Suzuki, Toshiaki Tamaki and Itsuo Katoh :
Effect of Amiloride on Ischaemia and Reperfusion Injury in Isolated,Perfused Rat Hearts,
Scandinavian Cardiovascular Journal, Vol.32, No.3, 167-172, 1998.
122.Masanori Yoshizumi, Tetsuya Kitagawa, Yutaka Masuda, Kazuya Horike, Y Ogawa, Y Suzuki, Toshiaki Tamaki and Itsuo Katoh :
Effect of amiloride on ischemia and reperfusion injury in isolated, perfused rat hearts.,
Scand. Cardiovasc. J., Vol.32, No.3, 167-172, 1998.
123.Masanori Yoshizumi, Daisuke Inui, Naoko Okishima, Hitoshi Houchi, Koichiro Tsuchiya, Hideki Wakabayashi, Hiroshi Kido and Toshiaki Tamaki :
Endothelin-1(1-31), a novel vasoactive peptide, increases [Ca2+]i in humen coronary artery smooth muscle cells.,
European Journal of Pharmacology, Vol.348, No.2-3, 305-309, 1998.
124.Kenzo Itoh, Masanori Yoshizumi, Tetsuya Kitagawa, Yasushi Fukuta, Takaki Hori, Hitoshi Houchi, Toshiaki Tamaki and Itsuo Katoh :
Extracellulary administered lysophosphatidylcholine causes Ca2+ efflux from freshly isolated adult rat cardiomyocytes,
Basic Research in Cardiology, Vol.93, No.1, 23-29, 1998.
(PubMed: 9538934)
125.Yasushi Fukuta, Masanori Yoshizumi, Tetsuya Kitagawa, Takaki Hori, Katoh Istuo, Hitoshi Houchi and Toshiaki Tamaki :
Effect of Angiotensin II on Ca2+ Efflux from Freshly Isolated Adult Rat Cardiomyocytes, --- Possible Involvement of Na+/Ca2+ Exchanger ---,
Biochemical Pharmacology, Vol.55, 481-487, 1998.
126.Chen Chunhe, Hitoshi Houchi, Toshiaki Tamaki and Yutaka Nakaya :
Effects of cytosolic ATP and other nucleotides on Ca2+-activated K+ channels in cultures bovine adrenal chromaffin cells.,
European Journal of Pharmacology, Vol.350, 293-299, 1998.
127.Toshiataka Ikehara, Park Ho Ki, Hitoshi Houchi, Keiko Hosokawa, Masayuki Shono, Kazuo Minakuchi, Toshiaki Tamaki, Yohsuke Kinouchi, Kazuo Yoshizaki and Hiroshi Miyamoto :
Effects of a time-varying strong magnetic field on transient increase in cytosolic free-Ca2+ induced by bradykinin in cultured bovine adrenal chromaffin cells.,
FEBS Letters, Vol.435, 229-232, 1998.
128.Masanori Yoshizumi, Shokei Kim, Shoji Kagami, Akinori Hamaguchi, Koichiro Tsuchiya, Hitoshi Houchi, Hiroshi Iwao, Hiroshi Kido and Toshiaki Tamaki :
Effect of endothelin-1(1-31)on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells.,
British Journal of Pharmacology, Vol.125, No.5, 1019-1027, 1998.
129.Masanori Yoshizumi, Tetsuya Kitagawa, Yuichi Ozawa, Kasutoshi Tano, Koichiro Tsuchiya, Hitoshi Houchi, Kazuo Minakuchi and Toshiaki Tamaki :
Changes in plasma free and sulfoconjugated catecholamines during the perioperative period of cardiac surgery:Effect of continuous infusion of dopamine.,
Biological & Pharmaceutical Bulletin, Vol.21, 787-791, 1998.
130.Kenzo Ito, Masanori Yoshizumi, Tetsuya Kitagawa, Yasushi Fukuta, Takaki Hori, Hitoshi Houchi, Toshiaki Tamaki and Itsuo Katoh :
Extracellulary administered lysophosphatidylcholine causes Ca2+ efflux from freshly isolated adult rat cardiomyocytes.,
Basic Res Cardiol., Vol.93, 23-29, 1998.
131.Hiroshi Kido, Ayako Nakano, Naoko Okishima, Hideki Wakabayashi, Fumiko Kishi, Yutaka Nakaya, Masanori Yoshizumi and Toshiaki Tamaki :
Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins.,
The Journal of Biological Chemistry, Vol.379, 885-891, 1998.
132.Masanori Yoshizumi, Tetsuya Kitagawa, Fukuta Y, Hori T, Hitoshi Houchi, Toshiaki Tamaki and Itsuo Katoh :
Extracellulary administered lysophosphatidylcholine causes Ca2+ efflux from freshly isolated adult rat cardiomyocytes.,
Basic Res Cardiol., Vol.93, 23-29, 1998.
133.Takaki Hori, Masanori Yoshizumi, Tetsuya Kitagawa, Hitoshi Houchi, Toshiaki Tamaki and Itsuo Katoh :
Extracelluar adenosine 5'-triphosphate induces Ca2+ effulux from freshly isolated adult rat cardiomyocytes:Possible involvement of Na+/Ca2+ exchange mechanism.,
Life Sciences, Vol.61, No.17, 1679-1689, 1997.
134.Masanori Yoshizumi, Hitoshi Houchi, Yasuo Ishimura, Masao HIrose, Tetsuya Kitagawa, Koichiro Tsustiya, Kazuo Minakuchi and Toshiaki Tamaki :
Effect of evodiamine on catecholamine secretion from bovine adrenal medulla.,
The Journal of Medical Investigation : JMI, Vol.44, No.1,2, 79-82, 1997.
(Tokushima University Institutional Repository: 111645,   PubMed: 9395722)
135.Hitoshi Houchi, Masanori Yoshizumi, Kazuo Minakuchi, Yasuko Ishimura, Kyoji Morita, Toshiaki Tamaki and Motoo Oka :
Potentiation of histamine-induced catecholamine secretion by ouabain in cultured bovine adrenal chromaffin cells is dependent on calcium and sodium influx.,
Life Sciences, Vol.60, No.23, 2051-2058, 1997.
136.Kazuo Minakuchi, Hitoshi Houchi, Masanori Yoshizumi, Yasuko Ishimura, Kyoji Morita, Masumitsu Takasugi, Motoo Oka and Toshiaki Tamaki :
Serotonin increases Na+-dependent Ca2+ efflux from bovin sdrenal chromaffin cells in culture.,
Neuroscience Letters, Vol.223, 17-20, 1997.
137.Masanori Yoshizumi, Hitoshi Houchi, T Tuchiya, Kazuo Minakuchi, Kazuya Horike, Tetsuya Kitagawa, Itsuo Katoh and Toshiaki Tamaki :
Atrial natriuretic peptide stimulates Na+-dependent Ca2+ effulux from freshly isolated adult rat cardiomyocytes.,
FEBS Letters, Vol.419, No.2,3, 255-258, 1997.
138.Kazuya Horike, Masanori Yoshizumi, Tetsuya Kitagawa, Katoh Itoh, Hitoshi Houchi, Toshiaki Tamaki and Itsuo Katoh :
Neuropeptide Y as a stimulator of Na+-dependent Ca2+ effulux from freshly isolated adult rat cardiomyocytes,
Naunyn-Schmiedeberg's Arch Pharmacol, Vol.356, No.6, 756-762, 1997.

Academic Paper (Unrefereed Paper):

1.Shuhei Tomita and Toshiaki Tamaki :
[Role of hypoxemia inducible transcription factor in tissue remodeling].,
Folia Pharmacologica Japonica, Vol.133, No.5, 298, 2009.
(PubMed: 19554786,   CiNii: 10025740819,   Elsevier: Scopus)
2.Yoshiko Fujita, Masanori Yoshizumi, Yuki Izawa, Yasuhisa Kanematsu and Toshiaki Tamaki :
Lysophosphatidylcholine(LPC)transactivates vascular endothelial growth factor(VEGF) receptor via c-Src in HUVEC,
Shikoku Acta Medica, Vol.61, No.3,4, 91-94, 2005.
(Tokushima University Institutional Repository: 47262,   CiNii: 40007059225)
3.Yasuhisa Kanematsu, Koichiro Tsuchiya and Toshiaki Tamaki :
生体内における亜硝酸由来のNO産生と,その循環動態への作用検討,
Japanese Journal of Circulation Research, Vol.28, No.2, 39-45, 2005.
(CiNii: 10016130791)
4.吉栖 正典, Koichiro Tsuchiya, Yasuhisa Kanematsu and Toshiaki Tamaki :
Endothelin in cardiac injury,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.62, No.9, 622-625, 2004.
5.藤守 義光, Yoshiyasu Terashima, Toshiaki Tamaki, Hiroki Moriguchi, 相野田 紀子 and Yoshio Kashida :
医療のエスノメソドロジー研究の現状と課題,
Social Science Research University of Tokushima, Vol.17, No.17, 207-253, 2004.
(Tokushima University Institutional Repository: 208,   CiNii: 110006555939)
6.Koichiro Tsuchiya, 吉栖 正典 and Toshiaki Tamaki :
亜硝酸と一酸化窒素(NO),
Japanese Journal of Circulation Research, Vol.25, No.2, 63-71, 2002.
(CiNii: 10012241553)
7.Masanori Yoshizumi, 沖嶋 直子, Daisuke Inui, Koichiro Tsuchiya and Toshiaki Tamaki :
エンドセリン1(1-31)の腎作用,
腎と透析, Vol.49, No.4, 739-743, 2000.
8.Toshiaki Tamaki and 吉栖 正典 :
腎微小循環,
Folia Pharmacologica Japonica, Vol.113, 261-267, 1999.
9.Daisuke Inui, Kazuyoshi Kirima, Yuichi Ozawa, Yuki Suzaki, Toyoshi Hasegwa, Koichiro Tsuchiya, Masanori Yoshizumi and Toshiaki Tamaki :
単離ウサギ輸入及び輸出細動脈におけるアデノシン受容体,
Shikoku Acta Medica, Vol.55, No.3, 124-130, 1999.
(Tokushima University Institutional Repository: 112145)

Review, Commentary:

1.MASAKI IMANISHI, Keisuke Ishizawa, TAKUMI SAKURADA, Yuki Izawa-Ishizawa, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Drug development for cardiorenal disease based on oxidative stress control,
Journal of the Pharmaceutical Society of Japan, Vol.134, No.6, 715-719, Jun. 2014.
(DOI: 10.1248/yakushi.13-00255-4,   PubMed: 24882646)
2.Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
抗酸化薬,
腎・高血圧の最新治療, Vol.3, No.2, 93-99, Apr. 2014.
3.Masaki Imanishi, Keisuke Ishizawa, 櫻田 巧, Yuki Izawa-Ishizawa, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
酸化ストレス制御を基盤とする新規心腎血管障害治療薬の開発,
Journal of the Pharmaceutical Society of Japan, Vol.134, No.6, 715-719, 2014.
4.Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Role of Dietary Essential Trace Metals in the Pathogenesis of Diabetes Mellitus,
Journal of the The Japan Diabetes Society, Vol.56, No.12, 919-921, Dec. 2013.
(CiNii: 40019952227,   Elsevier: Scopus)
5.Shuhei Tomita, Yoshitaka Kihira and Toshiaki Tamaki :
Pathophysiological responses to hypoxia in vascular remodeling by hypoxia-inducible factor-1,
Seikagaku, Vol.85, No.4, 265-268, Apr. 2013.
(PubMed: 23717872,   CiNii: 10031169567)
6.櫻田 巧, Keisuke Ishizawa, Masaki Imanishi, 藤井 聖子, 谷口 順平, Yuki Izawa-Ishizawa, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineはangiotensin IIによるマウス血管リモデリングを抑制する,
腎とフリーラジカル, Vol.11, 78-81, Jan. 2013.
7.Yasumasa Ikeda, Soichiro Tajima, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron metabolism in the progression of adipocyte hypertrophy,
The Cell, Vol.44, No.6, 282-286, Jun. 2012.
8.Yasumasa Ikeda, 田島 壮一郎, Noriko Yamano, Koichiro Tsuchiya and Toshiaki Tamaki :
The role of iron on cardiovascular disease and diabetes mellitus,
Japanese Journal of Circulation Research, Vol.34, No.2, 75-85, Jul. 2011.
(CiNii: 10029400903)
9.Shuhei Tomita, Masaki Imanishi, Takumi Sakurada, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda and Toshiaki Tamaki :
Role of Hypoxia-Inducible Factor1a (HIF-1a) in T cells in development of vascular remodeling,
Shikoku Acta Medica, Vol.67, No.1, 2, 3-6, Apr. 2011.
(Tokushima University Institutional Repository: 110344,   CiNii: 40018825645)
10.Keisuke Ishizawa, Kazuo Minakuchi and Toshiaki Tamaki :
医療人としての薬剤師育成教育の実践,
Medicine and Drug Journal, Vol.43, No.3, 871-874, Mar. 2007.
11.Toshiaki Tamaki, Kunihisa Yamaguchi and Keisuke Ishizawa :
薬理作用から見た健康食品,
Shikoku Acta Medica, Vol.63, No.5,6, 170-171, 2007.
(Tokushima University Institutional Repository: 110195)
12.Masanori Yoshizumi, Keisuke Ishizawa, Yuki Izawa and Toshiaki Tamaki :
Intracellular signal transduction of vascular injury in insulin resistance,
Folia Pharmacologica Japonica, Vol.128, No.3, 147-151, Sep. 2006.
(DOI: 10.1254/fpj.128.147,   PubMed: 16971777,   CiNii: 10018399832)

Proceeding of International Conference:

1.Licht Miyamoto, 粟飯原 遥奈, 許文 てい, ジン 美娜, 冨田 洋介, 山岡 朋美, Naonobu Tanaka, Yasumasa Ikeda, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
スダチ果皮からの抗メタボリックシンドローム活性を有する物質の同定,
日本糖尿病学会, Kyoto,
2.Keisuke Oshima, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron Supplementation Reduces Erythropoietin Expression through Hypoxia-Inducible Factor-2 alpha Inactivation via Oxidative Stress, ASN2016,
Chicago,
3.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Utilizing Real-World Big Data in the Search for New Renoprotective Drugs,
Joint Hypertension 2018 Scientific Sessions, Sep. 2018.
4.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Renoprotective effects of edoxaban, a factor Xa inhibitor,
18th World Congress of Basic and Clinical Pharmacology, Jul. 2018.
5.Yuki Izawa-Ishizawa, Masaki Imanishi, kotoko suzuki, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Koichiro Tsuchiya, Toshiaki Tamaki, Keisuke Ishizawa and Yasumasa Ikeda :
The effect of quercetin on aortic aneurysms in mice,
WCP2018, Jul. 2018.
6.濱野 裕章, Yasumasa Ikeda, Yuya Horinouchi, Yoshito Zamami, Masaki Imanishi, Yuki Izawa-Ishizawa, Licht Miyamoto, Koichiro Tsuchiya, Keisuke Ishizawa and Toshiaki Tamaki :
Proton Pump Inhibitor Involves Abnormality of Iron Metabolism through Hepcidin Regulation,
18th World Congress of Basic and Clinical Pharmacology, Jul. 2018.
7.Yoshito Zamami, Yuki Izawa-Ishizawa, Kenshi Takechi, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Toshiaki Tamaki and Keisuke Ishizawa :
Search for drugs that attenuate the anti tumor effect of bevacizumab using adverse event database,
18th World Congress of Basic and Clinical Pharmacology, Jul. 2018.
8.Licht Miyamoto, Aihara Haruna, Xu Wenting, Jin Meina, Tomida Yosuke, Yamaoka Tomomi, Tanaka Naonobu, Ikeda Yasumasa, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
A limonene-derivative purified from peels of Citrus Sudachi ameliorates lipid and glucose metabolism through upregulating sirt1,
World Congress of Pharmacology, Kyoto, Jul. 2018.
9.Yuya Horinouchi, Yasumasa Ikeda, Hirofumi Hamano, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The effect of iron on skeletal muscle atrophy in chronic kidney disease.,
Free Radical Biology and Medicine, Vol.112, No.1, 204-205, Dec. 2017.
(DOI: 10.1016/j.freeradbiomed.2017.10.323)
10.hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Indoxyl Sulfate Disturbs Normal Iron Metabolism via Hepcidin Upregulation in Chronic Kidney Disease,
ASN Kidney Week 2017 Annual Meeting, Nov. 2017.
11.Yuya Horinouchi, Yasumasa Ikeda, Masaki Imanishi, Yoshito Zamami, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Direct activated factor X inhibitor attenuates renal fibrosis on unilateral ureteral obstruction-induced nephrotoxicity.,
53rd Congress of the European Societies of Toxicology (eurotox2017), Sep. 2017.
12.Yuya Horinouchi, Yasumasa Ikeda, Masaki Imanishi, Yoshito Zamami, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
FACTOR XA INHIBITOR ATTENUATES RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION,
THE 13TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS(EACPT2017), Jun. 2017.
13.Yuki Izawa-Ishizawa, Keisuke Ishizawa, 田淵 正樹, Masaki Imanishi, Mai Takata, Eriko Sairyo, Yoshito Zamami, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
NITROSONIFEDIPINE, A NOVEL ANTIOXIDANT, AMELIORATES NEUROLOGICALSYMPTOMS AND PROLONGS THE SURVIVAL IN A MALIGNANT STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS,
27th European Meeting on Hypertension and Cardiovascular Protection, Jun. 2017.
14.Masaki Imanishi, Kyohei Tanaka, Raiki Ikutoh, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
THE EFFECTS OF FEBUXOSTAT ON ANGIOTENSIN II-INDUCED VASCULAR REMODELING,
27th European Meeting on Hypertension and Cardiovascular Protection, Jun. 2017.
15.Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
IRON RESTRICTION PREVENTS RENAL TUBULOINTERSTITIAL INJURY INDUCED BY ALBUMIN OVERLOAD IN MICE,
54th ERA-EDTA Congress, Madrid, Jun. 2017.
16.Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
DIRECT FACTOR XA INHIBITOR PREVENTS RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION,
54th ERA-EDTA Congress, Madrid, Jun. 2017.
17.Licht Miyamoto, Fukuta Keisuke, Takahashi Rie, Umemoto Kana, Okuno Hiroko, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
Fragrance of aromatic oil from peels of Citrus sudachi causes adipose browning and ameliorates glucose and lipid metabolism,
EMBO workshop, Sitges, Spain, May 2017.
18.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Indoxyl Sulfate Involves Abnormality of Iron Metabolism through Hepcidin Regulation,
Experimental Bioogy 2017, Chicago, Apr. 2017.
19.Koichiro Tsuchiya, Aihara Haruna, Xu Wenting, Jin Meina, Tomida Yosuke, Yamaoka Tomomi, Naonobu Tanaka, Yasumasa Ikeda, Akira Shigenaga, Akira Otaka, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
A limonene-derivative from Sudachi peel activates sirt1 and improves lipid and glucose metabolism in high fat diet-fed mice.,
欧州糖尿病学会, Dec. 2016.
20.Ota Kazuma, Yoshitaka Kihira, Kishibuchi Reina, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda and Toshiaki Tamaki :
Disruption of hypoxia-inducible factor-1a deteriorates renal ischemia-reperfusion injury through dysregulation of Kv2.2-induced apoptosis in tubules.,
ASN KIDNEY WEEK 2016, Chicago, Nov. 2016.
21.Maki Urushihara, T Nagai, Shuji Kondo, Toshiaki Tamaki, Yasumasa Ikeda and Shoji Kagami :
(Pro)renin receptor-mediated ERK1/2 and Wnt signaling pathway in crescent glomerulonephritis.,
Kidney Week 2016, Nov. 2016.
22.Yoshito Zamami, Mitsui Marin, Moriguchi Hiroshi, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Kawasaki Hiromu, Toshiaki Tamaki and Keisuke Ishizawa :
Search for a preventative therapy for Bevacizumab-induced hypertension using the drug repositioning approach,
7th Scientific Meeting of Asian Society for Vascular Biology, Oct. 2016.
23.Fukuta Keisuke, Licht Miyamoto, Takahashi Rie, Toshiaki Tamaki, Ikeda Yasumasa and Tsuchiya Koichiro :
Eessential oil from sudachi peal improves glucose and lipid metabolism, 11th IDF-WPR Congress 2016 & 8th AASD Scientific Meeting (Taipei, Taiwan),
Oct. 2016.
24.Yutaka Fukunaga, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Ichiro Hashimoto :
Topical Application of Nitrosonifedipine, a Novel Free Radical Scavenger, Ameliorate the Ischemic Skin Flap Necrosis,
Plastic Surgery THE MEETING 2016, Los Angeles, Sep. 2016.
25.Yuki Izawa-Ishizawa, Masaki Imanishi, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
The effects of pitavastatin, a lipid-lowering agent, against aortic dissection model mice induced by L-NAME, a nitric oxide synthase inhibitor.,
The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan., May 2016.
26.Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
The new insight of iron on tissue damage in metabolic disorders.,
The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan., May 2016.
27.Koichiro Tsuchiya, Licht Miyamoto, Tomida Yosuke, Yamane Megumi, Tsuda Katsunori, Yasumasa Ikeda and Toshiaki Tamaki :
Dietary nitrite ameliorates glucose tolerance and hyperlipidemia in diet-induced obesity rats.,
The 16th Annual Scientific Meeting of the Nitric Oxide Society of Japan / The 9th Internatinal Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide. (Seindai, Japan) 2016.5, May 2016.
28.Yasumasa Ikeda, Keisuke Oshima, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The Involvement of Iron Supplementation on Erythropoietin Expression,
Experimental Biology 2016, Apr. 2016.
29.FUKUTA Keisuke, Licht Miyamoto, TAKAHASHI Rie, Toshiaki Tamaki, Yasumasa Ikeda and Koichiro Tsuchiya :
11th IDF-WPR Congress 2016 & 8th AASD Scientific MeetingPosterEessentialoil fromsudachipealimprovesglucoseandlipidmetabolism,
2016.
30.Licht Miyamoto, Yuki Tsuchihashi, Yosuke Tomida, Megumi Yamane, Kazuya Takenokuma, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
Dietary nitrite ameliorates glucose tolerance and hyperlipidemia in diet-induced obese rats,
The 6th International Conference on Food Factors, Seoul, Nov. 2015.
31.Yasumasa Ikeda, Hamano Hirofumi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Bilirubin Enhances Ischimia-induced Angiogenesis Through Akt-eNOS-Dependent Signaling Pathway,
American Heart Association Scientific Sessions 2015, Orlando, Nov. 2015.
32.Wenting Xu, Licht Miyamoto, Haruna Aihara, Tomomi Yamaoka, Keisuke Ishizawa, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
The Mechanism of Citrus sudachi Peel Extract Exerts Lipid Reducing Effect in Cells,
2015.10.19-22 The 10th IAGG Asia / Oceania Congress of Gerontology and Geriatrics 2015, Chiang Mai, Oct. 2015.
33.Licht Miyamoto, 粟飯原 遥奈, Wenting Xu, Meina Jin, 冨田 洋介, 山岡 朋美, Naonobu Tanaka, Yasumasa Ikeda, Akira Shigenaga, Akira Otaka, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
リモネン誘導体によるsirt1活性化を介した脂質低下作用,
日本肥満学会,アジアオセアニア糖尿病学会, Nagoya, Oct. 2015.
34.Licht Miyamoto, Haruna Aihara, Wenting Xu, Meina Jin, Yosuke Tomida, Tomomi Yamaoka, Naonobu Tanaka, Yasumasa Ikeda, Akira Shigenaga, Akira Otaka, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
Limonene-derivative Ameliorates Lipid Profiles by Upregulation of Sirt1 Activity and Expression in Cultured Cells and High Fat Diet-Fed Mice,
American diabetes association, Boston, Jun. 2015.
35.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Toya Hiroki, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Novel aortic dissection model by pharmacologically-induced endothelial dysfunction,
17th International Congress on Atherosclerosis 2015, Amsterdam, May 2015.
36.Yasumasa Ikeda, Yusuke Kanai, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The Effects of Bilirubin on Angiogenesis in Mice with Hindlimb Ischemia,
Experimental Biology 2015, Boston, Mar. 2015.
37.Masaki Imanishi, 井口 道代, 冨田 紀子, Tsounapi Panagiota, 松永 慎司, Toshiaki Tamaki and Shuhei Tomita :
平滑筋由来HIF-1αは薬剤誘導性大動脈瘤形成に対して保護的に作用する,
第1回国際心血管薬物療法学会日本部会, 2015.
38.Yuya Horinouchi, A Fiona Summers, Marilyn Ehrenshaft, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Toshiaki Tamaki and P Ronald Mason :
Investigating free radical generation in HepG2 cells using immuno-spin trapping.,
Free Radical Biology and Medicine, Vol.75 Suppl 1, Dec. 2014.
(DOI: 10.1016/j.freeradbiomed.2014.10.768,   PubMed: 26461344)
39.Jamba Ariunbold, Shuji Kondo, Nagai Takashi, Maki Urushihara, Toshiaki Tamaki and Shoji Kagami :
Hic-5 Regulates Mesangial Cell Proliferation via Altered and Coordinated Expression of Cell Cycle-Related Protein,
American Society of Nephrology (ASN) Kidney Week 2014, Philadelphia, Nov. 2014.
40.Maki Urushihara, Shuji Kondo, Kobori Hiroyuki, Toshiaki Tamaki and Shoji Kagami :
Urinary angiotensinogen as a specific biomarker of intrarenal renin-angiotensin system status associated with glomerular injury in pediatric IgA nephropathy patients,
American Society of Nephrology (ASN) Kidney Week 2014, Philadelphia, Nov. 2014.
41.Keisuke Ishizawa, Kohara Yusuke, Sakurada Takumi, Toya Hiroki, Iki Yutaka, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates the progression of aortic aneurysms by exerting antioxidative effects,
ESC Congress 2014, Barcelona, Sep. 2014.
42.Yasumasa Ikeda, Soichiro Tajima, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Ferritin induces IL-1 production through inflammasome activation via NF-B-dependent manner in macrophages,
Experimental Biology 2014, San Diego, Apr. 2014.
43.Licht Miyamoto, Yamane Megumi, Tomida Yosuke, Takenokuma Kazuya, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
Significance of AMPK in renal protective and metabolic actions of nitrite,
international conference of food science, Kyoto, Mar. 2014.
44.Licht Miyamoto, Tomida Y, Takenokuma K, Yamane M, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
Dietary nitrite ameliorates glucose and lipid metabolism in high fat diet-fed rats.,
2014 Keystone Symposia Conference, Jan. 2014.
45.Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Yasushi Yoshida, Yoichiro Hirata, Mie Sakata, Mark Webster Maxfield, Michio Shimabukuro, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa and Shuhei Tomita :
Macrophage-Specific Hypoxia-Inducible Factor (HIF)-1-Deficient Mice Suppress the Vascular Remodeling and Regulate M2 Macrophage Polarization,
American Heart Association AHA 2013, Nov. 2013.
46.S Jamba, Shuji Kondo, Maki Urushihara, T Nagai, Toshiaki Tamaki and Shoji Kagami :
Contribution of hydrogen peroxide-inducible clone-5 to the regulation of mesangial cell proliferation in mesangioproliferative glomerulonephritis,
The annual meeting of American society of nephrology Kidney Week 2013, Nov. 2013.
47.Keisuke Ishizawa, Noriko Yamano, Hiroyuki Kobori, Maki Urushihara, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine prevents the progression of diabetic nephropathy via attenuating the expression of intrarenal angiotensinogen and oxidative stress,
High Blood Pressure Research 2013 Scientific Sessions, Sep. 2013.
48.Yuya Horinouchi, Fiona A. Summers, Marilyn Ehrenshaft, Hitoshi Houchi, Toshiaki Tamaki, Kazuo Minakuchi and Ronald P. Mason :
Cytotoxity evaluation of environmental chemicals via free radical detection using newly technique immuno-spin trapping, In-Cell Western and confocal microscopy,
49th Congress of the European Societies of Toxicology (EUROTOX), Sep. 2013.
49.Takumi Sakurada, K. Miyako, Yuya Horinouchi, Kazuhiko Teraoka, T. Kujime, Kazuyoshi Kawazoe, Hitoshi Houchi, Toshiaki Tamaki and Kazuo Minakuchi :
NITROSONIFEDIPINE, A PHOTODEGRADATION PRODUCT OF NIFEDIPINE, SUPPRESS THE PROGRESSION OF DIABETIC NEPHROPATHY WITH THE ENDOTHELIAL DYSFUNCTION,
11th EACPT Congress, Aug. 2013.
50.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakiko Doi, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Rho-kinase is involved in inorganic phosphate-induced ERK1/2 activation in vascular smooth muscle cells,
World Biotechnology Congress 2013, Jun. 2013.
51.Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
The effect of dietary iron restriction against diabetic nephropathy in db/db mice,
Experimental Biology 2013, Apr. 2013.
52.Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Mayuko Higashida, Yuki Matsuoka, Yasushi Yoshida, Yoichiro Hirata, Mie Sakata, Mark Webster Maxfield, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa and Shuhei Tomita :
Role of Macrophage-derived Hif-1a as a Mediator of Vascular Remodeling,
American Heart Association Scientific Sessions 2012, Nov. 2012.
53.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masataka Sata, Masashi Akaike, Toshio Matsumoto and Toshiaki Tamaki :
Heparin Cofactor II Promotes Angiogenesis in Response to Ischemic Hindlimb via an AMPK-eNOS-dependent Manner,
American Heart Association Scientific Sessions 2012, Nov. 2012.
54.Yusaku Maeda, Shuhei Tomita, Masaki Murakami, Hirotsugu Kurobe, Masaki Imanishi, Yasushi Yoshida, Yoichiro Hirata, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Tetsuya Kitagawa, Masataka Sata and Toshiaki Tamaki :
Deficiency of Hypoxia Inducible Factor-1a in SM-22a-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation,
American Heart Association Scientific Sessions 2012, Nov. 2012.
55.Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron Restriction Prevents the Progression of Diabetic Nephropathy in db/db Mice,
American Heart Association Scientific Sessions 2012, Nov. 2012.
56.Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible Factor-1a in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media,
American Heart Association Scientific Sessions 2012, Nov. 2012.
57.Hideaki Enomoto, Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Protective Effects of Iron-Restricted Food against Diabetic Nephropathy in db/db Mice,
American Heart Association High Blood Pressure Research 2012, Sep. 2012.
58.Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice,
American Heart Association High Blood Pressure Research 2012, Sep. 2012.
59.Mitsuru Takaku, Shuhei Tomita, Hirotsugu Kurobe, Akira Ushiyama, Ichiro Hashimoto, Toshiaki Tamaki and Hideki Nakanishi :
PRECONDITIONING BY SYSTEMIC INTRODUCTION OF A PROLYL HYDROXYLASE INHIBITOR, DIMETHYLOXALYLGLYCINE,PROMOTES PREVENTION OF SKIN FLAP NECROSIS VIA HIF-1-INDUCED BONE MARROW-DERIVED PROGENITOR CELLS,
4thCongress of the World Union of Wound Healing Societies, Yokohama, Sep. 2012.
60.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1a deficiency in smooth muscle cell attenuates angiotensin -induced vascular remodeling in mice,
ISOTT (International Society on Oxygen Transport to Tissue) 2012, Aug. 2012.
61.Takumi Sakurada, Keisuke Ishizawa, Shoko Fujii, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice,
Experimental Biology 2012, Apr. 2012.
62.Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron restriction prevents progression of diabetic nephropathy,
KEYSTONE SYMPOSIA 40th ANNIVERSARY 1972-2012 Complications of Diabetes: Mechanisms of Injury and Failure of Repair, Mar. 2012.
63.Maeda Yusaku, Shuhei Tomita, Murakami Masaki, Hirotsugu Kurobe, Masaki Imanishi, Yoshida Yasushi, Hirata Yoichiro, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Tetsuya Kitagawa, Masataka Sata and Toshiaki Tamaki :
Deficiency of Hypoxia Inducible Factor-1 in SM-22-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation,
AHA SCIENTIFIC SESSIONS 2012, 2012.
64.Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible Factor-1 in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media,
AHA SCIENTIFIC SESSIONS 2012, 2012.
65.Fujii Shoko, Keisuke Ishizawa, Sakurada Takumi, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Nuno Asami, Suzuki Yuta, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice,
HIGH BLOOD PRESSURE RESEARCH 2012 SCIENTIFIC SESSIONS, 2012.
66.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1 deficiency in smooth muscle cell attenuates angiotensin II-induced vascular remodeling in mice,
The International Society on Oxygen Transport to Tissue 2012, 2012.
67.Shuhei Tomita, Masaki Imanishi, Yoshitaka Kihira, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II-induced vascular remodeling is mediated by hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells,
The 33rd Naito Conference, 2012.
68.Sakurada Takumi, Keisuke Ishizawa, Fujii Shoko, Yuki Izawa-Ishizawa, Masaki Imanishi, Nuno Asami, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice,
Experimental Biology 2012, 2012.
69.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Smooth Muscle Cell-Specific Hypoxia-Inducible Factor-1a Deficiency Attenuates Angiotensin II-Induced Vascular Remodeling in Mice,
AHA scientific sessions 2011, Orlando, Nov. 2011.
70.Soichiro Tajima, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
Inhibition of Adipocyte Hypertrophy by Deferoxiamine Diabetic KKAy mice,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
71.Kazuyuki Yamaguchi, Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Glucose Metabolism of Adipocytes is Regulated by Basic Fibroblast Growth Factor via Hypoxia-inducible Factor-1a,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
72.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible Factor-1a Deficiency in Smooth Muscle Cells Suppresses Angiotensin -induced Vascular Remodeling in Mice,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
73.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Shuhei Tomita, Masataka Sata, Masashi Akaike, Shigeki Kato, Toshio Matsumoto and Toshiaki Tamaki :
Heparin Cofactor Promotes Angiogenesis via an AMPK-eNOS Signaling Pathway,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
74.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin -induced Vascular Remodeling is Improved by Nitrosonifedipine, a Possible New Class Drug Against Oxidative Stress,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
75.Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitorosonifedipine is a new class drug to improves angiotensin II-induced vascular remodeling,
European Society of Cardiology Congress 2011, Aug. 2011.
76.Mitsuru Takaku, Shuhei Tomita, Hirotsugu Kurobe, Ichiro Hashimoto, Hideki Nakanishi and Toshiaki Tamaki :
Preconditioning of mice with a PHD inhibitor, dimethyloaxylglycine, prevent skin flap necrosis,
ISOTT (International Society on Oxygen Transport to Tissue) 2011, Georgetown, Jul. 2011.
77.Shuhei Tomita, Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Characterization on mice lacking HIF1a gene in renal ischemia-reperfusion injury,
ISOTT (International Society on Oxygen Transport to Tissue) 2011, Washington, D.C., Jul. 2011.
78.Yasumasa Ikeda, Soichiro Tajima, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Estrogen action on iron metabolism,
ENDO 2011: The 93rd Annual Meeting & Expo, Boston, Jun. 2011.
79.Shuji Kondo, S Matsuura, Yukiko Kinoshita, Ken-ichi Suga, Maki Urushihara, T Nagai, Toshiaki Tamaki and Shoji Kagami :
The expression of NADPH oxidase and reactive oxygen species (ROS) production contribute to ureteric bud branching and nephrogenesis,
World Congress of Nephrology 2011, Apr. 2011.
80.Masaki Imanishi, Soichiro Tajima, Yoshitaka Kihira, Keisuke Ishizawa, Shuji Kondo, Shoji Kagami, Shuhei Tomita, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Increment intracellular labile iron enhances Angiotensin-induced intracellular adhesion molecule-1 (ICAM-1) expression in human glomerular endothelial cells,
World congress of Nephrology 2011, Vancouver, Apr. 2011.
81.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Smooth Muscle Cell-specific Hypoxia-inducible Factor-1a Deficiency Attenuates Angiotensin II-induced Vascular Remodeling In Mice,
AHA SCIENTIFIC SESSIONS 2011, 2011.
82.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakurada Takumi, Masaki Imanishi, Fujii Shoko, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II-induced Vascular Remodeling Is Improved By Nitrosonifedipine, A Possible New Class Drug,
HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS, 2011.
83.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible Factor-1 Deficiency In Smooth Muscle Cells Suppresses Angiotensin II-induced Vascular Remodeling In Mice,
HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS, 2011.
84.Keisuke Ishizawa, Sakurada Takumi, Masaki Imanishi, Fujii Shoko, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitorosonifedipine is a new class drug to improve angiotensin II-induced vascular remodeling,
ESC Congress 2011, 2011.
85.Masaki Imanishi, Tajima Soichiro, Yoshitaka Kihira, Keisuke Ishizawa, Shuji Kondo, Shoji Kagami, Shuhei Tomita, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
INCREMENT INTRACELLULAR LABILE IRON ENHANCES ANGIOTENSIN II-INDUCED INTRACELLULAR ADHESION MOLECULE-1 (ICAM-1) EXPRESSION IN HUMAN GLOMERULAR ENDOTHELIAL CELLS,
World Congress of Nephrology 2011, 2011.
86.Toshiaki Tamaki, Kunihisa Yamaguchi, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Shuji Kondo, Shoji Kagami and Shuhei Tomita :
Global gene expression analyses in renal ischemia-reperfusion injury (IRI) from mice lucking Hif-1a gene,
ASN RENAL WEEK 2010 EXHIBIT, Nov. 2010.
87.Koichiro Tsuchiya, Yuya Horinouchi, Soichiro Tajima, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Yoshiyuki Yoshimura, Shuhei Tomita, Shuichi Hamano and Toshiaki Tamaki :
Antioxidant effects of photodegradation product of nifedipine,
17th Annual Meeting of the Society for Free Radical Biology and Medicine (SFRBM 2010), Nov. 2010.
88.Matsuura Sato, Shuji Kondo, Ken-ichi Suga, Yukiko Kinoshita, Maki Urushihara, Toshiaki Tamaki and Shoji Kagami :
Reactive oxygen species (ROS) produced by NADPH oxidase contribute ureteric bud branching and nephrogenesis,
ASN 2010, Colorado, Nov. 2010.
89.Shuhei Tomita, Masahisa Urata, Yayoi Fukuhara, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Tetsuya Kitagawa and Toshiaki Tamaki :
Endothelial-targeted hypoxia-inducible factor-1b (HIF-1b) loss-of function alleviates the monocrotaline-induced pulmonary hypertension in mice,
American Heart Association Scientific Sessions 2010, Chicago, Nov. 2010.
90.Keisuke Ishizawa, Masaki Imanishi, Yuya Horinouchi, Yayoi Fukuhara, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Yoshitaka Kihira, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitroso-nifedipine is a new class drug to protect endothelial function for overcoming organ damage,
International Society of Hypertension 2010, Vancouver, Sep. 2010.
91.Soichiro Tajima, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
IRON DERIVATION AMELIORATES GLUCOSE TOLERANCE THROUGH REDUCTION OF OXIDATIVE STRESS AND INFLAMMATION IN DIABETIC KKAY MICE,
2010 American Physiological Society Conference Inflammation, Immunity and Cardiovascular Disease, Aug. 2010.
92.Sato Matsuura, Shuji Kondo, Ken-ichi Suga, Yukiko Kinoshita, Toshiaki Tamaki and Shoji Kagami :
Expression and localization of focal adhesion proteins in the developing rat kidney,
The 15th Congress of the International Pediatric Nephrology Association, Aug. 2010.
93.Yayoi Fukuhara, Shuhei Tomita, Yuko Imamura, Yuya Horinouchi, Masaki Imanishi, Takumi Sakurada, Tetsuya Kitagawa and Toshiaki Tamaki :
Role of HIF-1b in endothelial cells in monocrotaline-induced pulmonary hypertension in mice,
16th World Congress on Basic and Clinical Pharmacology, Jul. 2010.
94.Yoshitaka Kihira, Shuhei Tomita, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Basic fibroblast growth factor upregulates hypoxia inducible factor 1 and glucose transporter 1 in adipose cells,
The 16th World Congress of Basic and Clinical Pharmacology (WorldPharma 2010), Copenhagen, Jul. 2010.
95.Soichiro Tajima, Yasumasa Ikeda, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi, Toshiaki Tamaki and Koichiro Tsuchiya :
Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway,
The 6th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide, Jun. 2010.
96.Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Toshiaki Tamaki and Koichiro Tsuchiya :
Metabolism of quercetin in vivo and its protective effect against cardiovascular diseases,
2nd International On-Board Symposium: Human Health, Energy and Environment, May 2010.
97.Yasumasa Ikeda, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway,
XX World Congress ISHR 2010 KYOTO, May 2010.
98.Toshiaki Tamaki, Kunihisa Yamaguchi, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Shuhei Tomita :
Amelioration of acute tubular necrosis in ischemic acute renal failure was impaired in mice lucking hypoxia inducible factor-1 gene,
ISN (International Society of Nephrology) nexus sympojium 2010, Apr. 2010.
99.Souichiro Tajima, Yasumasa Ikeda, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi, Toshiaki Tamaki and Koichiro Tsuchiya :
Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway,
The 6th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide, Kyoto, Apr. 2010.
100.Shuji Kondo, Ken-ichi Suga, sato Matsuura, Yukiko Kinoshita, Maki Urushihara, Toshiaki Tamaki and Shoji Kagami :
Enhanced expression of Hic-5 is involved in the development of human and rat mesangioproliferative glomerulonephritis,
ISN-Nexus Kyoto Symposium 2010, Apr. 2010.
101.Gang Liu, Kayoko Miyata, Hirofumi Hitomi, Li Yao, Guang-Ping Sun, Yuki Suzaki, Naohisa Hosomi, Hideyasu Kiyomoto, Daisuke Nakano, Toshiaki Tamaki, Masanori Yoshizumi and Akira Nishiyama :
Involvement of mineralocorticoid receptor in high glucose-induced big mitogen-activated protein kinase 1 activation and mesangial cell proliferation.,
Journal of Hypertension, Vol.28, No.3, 536-542, Mar. 2010.
(DOI: 10.1097/HJH.0b013e3283346b62,   PubMed: 20090557)
102.Koichiro Tsuchiya, Soichiro Tajima, Keisuke Ishizawa, Shuhei Tomita, Yoshitaka Kihira, Yasumasa Ikeda, Yoshiyuki Yoshimura, Shuichi Hamano and Toshiaki Tamaki :
Effect of Angiotensin II on the intracellular labile iron concentration in HGECs,
16th Annual Meeting of the Society for Free Radical Biology and Medicine (SFRBM 2009), Nov. 2009.
103.Yasumasa Ikeda, Kaori Sato, David Pimentel, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Flora Sam, Toshiaki Tamaki and Kenneth Walsh :
LKB1 gene in myocytes plays a critical role to regulate the coordinated cardiac growth and capillary development,
American Heart Association Scientific Sessions 2009, Orlando, Nov. 2009.
104.田島 壮一郎, Koichiro Tsuchiya, Yuya Horinouchi, 石澤 啓介, 寺岡 和彦, 冨田 修平, 川添 和義, 芳地 一, Toshiaki Tamaki and 水口 和生 :
ANGIOTENSIN II INCREASED INTRACELLULAR LABILE IRON IN THE PRESENCE OF TRANSFERRIN IN HGEC,
Basic & Clinical Pharmacology & Toxicology, Vol.105, 127, 2009.
105.Kunihisa Yamaguchi, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya, Shuji Kondo, Shoji Kagami and Toshiaki Tamaki :
Hypoxia-Inducible Factor-1α ameliorates ischemic acute renal failure and has a relation with a recovery from acute tubular necrosis,
41th ASN annual meeting, Philadelphia, Nov. 2008.
106.Toshiaki Tamaki, Keisuke Ishizawa, Kunihisa Yamaguchi, Shuji Kondo, Shoji Kagami, Fukuhara Yayoi, Yuya Horinouchi and Koichiro Tsuchiya :
Nitoroso-nifedipine is a new class drug to protect kidney against oxidative stress,
41th ASN annual meeting, Philadelphia, Nov. 2008.
107.Yuya Horinouchi, Koichiro Tsuchiya, 石澤 啓介, 田島 壮一郎, 元林 有紀, 山口 邦久, 川添 和義, Kazuo Minakuchi and Toshiaki Tamaki :
Endothelial cell protective activity of nitorosonifedipine,
Biomedical Redox Navigation (EPR2008), Fukuoka, Sep. 2008.
108.Koichiro Tsuchiya, Soichiro Tajima, Mai Hamamoto, Hideki Ohnishi, Yuki Motobayashi, Yuya Horinouchi, Kunihisa Yamaguchi, Keisuke Ishizawa, Kazuyoshi Kawazoe, Kazuo Minakuchi and Toshiaki Tamaki :
Effect of angiotensin II on iron (II) turnover in HGEC,
Biomedical Redox Navigation (EPR2008), Fukuoka, Sep. 2008.
109.Yuya Horinouchi, Koichiro Tsuchiya, Keisuke Ishizawa, Soichiro Tajima, Yuki Motobayashi, Kunihisa Yamaguchi, Kazuyoshi Kawazoe, Kazuo Minakuchi and Toshiaki Tamaki :
Endotherial cell protective activity of nitrosonifedipine,
Biomedical Redox Navigation (EPR2008), Fukuoka, Sep. 2008.
110.Yuki Motobayashi, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Sakiko Orino, Dorjsuren Narantungalag, Kunihisa Yamaguchi, Kazuo Minakuchi and Toshiaki Tamaki :
Inhibitory effects of adiponectin on cell migration induced by insulin-like growth factor-1 in vascular smooth muscle cells,
The IXth World Conference on Clinical Pharmacology and Therapeutics, Québec City, Jul. 2008.
111.Toshiaki Tamaki, Kunihisa Yamaguchi, Narantungalag Dorjsuren, Yayoi Fukuhara, Yuya Horinouchi, Yuki Motobayashi, Koichiro Tsuchiya and Keisuke Ishizawa :
Olmesartan inhibits the TNF-α-induced cytotoxicity in human glomerular endothelial cells,
ISN Nexus Symposium on Diabetes & the Kidney, Dublin, Jun. 2008.
112.Keisuke Ishizawa, Narantungalag Dorjsuren, Yuki Izawa-Ishizawa, Teppei Tsuneishi, Yuki Motobayashi, Hideki Ohnishi, Kunihisa Yamaguchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Inhibitory effects of olmesartan on TNF-α-induced cytotoxicity in human glomerular endothelial cells,
40th ASN annual meeting, San Francisco, Nov. 2007.
113.Maki Urushihara, Masanori Takamatsu, Maki Shimizu, Shuji Kondo, Akiko Kitamura, Yukiko Kinoshita, Keisuke Ishizawa, Toshiaki Tamaki and Shoji Kagami :
The role of extracellular signal regulated kinase 5 in the accumulation of collagen matrix in rat mesangioproliferative glomerulonephritis,
40th ASN annual meeting, San Francisco, CA, Nov. 2007.
114.Koichiro Tsuchiya, Satoshi Iwanaga, Hideki Ohnishi, Yayoi Fukuhara, Chiaki Taoka, Soichiro Tajima, Yuya Horinouchi and Toshiaki Tamaki :
In vivo and in vitro studies on NO formation from iron-quercetin-nitrite complexes,
Second International Role of Nitrite in Physiology, Pathophysiology and Therapeutics Meeting, Bethesda, Maryland, Sep. 2007.
115.Keisuke Ishizawa, Erika Miki, Arisa Hironaga, Koichiro Tsuchiya, Maki Urushihara, Shoji Kagami and Toshiaki Tamaki :
Angiotensin II receptor blocker inhibits PDGF-induced cell migration in rat mesangial cells,
39th ASN annual meeting 2006, San Diego, Nov. 2006.
116.Maki Urushihara, Masanori Takamatsu, Maki Shimizu, Shuji Kondo, Toshiaki Tamaki and Shoji Kagami :
Extracellular signal regulated kinase 5 induces mesangial cell survival in rat progressive mesangioproliferative glomerulonephritis,
39th ASN annual meeting 2006, San Diego, Nov. 2006.
117.Koichiro Tsuchiya, Yuya Horinouchi, Yasuhisa Kanematsu, Shinji Abe, Hideki Ohnishi, Soichiro Tajima, Keisuke Ishizawa, Toshiaki Tamaki and Yoshiharu Takiguchi :
Production of nitrosonifedipine radical from nifedipine and its antioxidative activity in cultured cells,
13th annual meeting of society of free radical and biology of medicine, Denver, Nov. 2006.
118.Hideki Ohnishi, Koichiro Tsuchiya, Yasuhisa Kanematsu, Shinji Abe, Soichiro Tajima and Toshiaki Tamaki :
Effects of quercetin on NO production from nitrite at physiological conditions,
20th Scientific Meeting of the International Soiciety of Hypertension, Fukuoka, Japan, Oct. 2006.
119.Hiroyuki Sakakibara, Yuki Izawa, Jun-ichiro Nakajima, Shujiro Seo, Toshiaki Tamaki, Yoshichika Kawai and Junji Terao :
Antidepressant effects of polyphenol rich herbal medicine, Ginkgo biloba, extracts in behavioral models,
232 nd American Chemical Society Meeting & Exposition, San Francisco, Sep. 2006.
120.Koichiro Tsuchiya, Yasuhisa Kanematsu, Keisuke Ishizawa, Shinji Abe, Hideki Ohnishi, Soichiro Tajima, Kazuyoshi Kawazoe, Yoshiharu Takiguchi and Toshiaki Tamaki :
Dietary nitrite is an alternative source of NO in vivo,
International Society for Radical Research 13th Biennial Congress, Davos, Switzerland, Aug. 2006.
121.Hirotsugu Kurobe, Yuki Izawa, Y Fukuhara, Tamotsu Kanbara, A Kurushima, Ken-ichi Aihara, Masashi Akaike, Masashi Kano, Takashi Kitaichi, Yutaka Masuda, Hiroyuki Azuma, Toshiaki Tamaki, Toshio Matsumoto, Tetsuya Kitagawa, Shuhei Tomita and Masanori Yoshizumi :
HIF-ARNT transcriptional system in Tcells has a pivotal role in vascular inflammation and remodeling,
XIL International Symposium on Atherosclerosis, Italy, Jun. 2006.
122.Yoshiyasu Terashima, Kazuo Mori, Takuji Kawano and Toshiaki Tamaki :
Four-hour student workshop for introduction to PBL tutorial learning program,
6th Asia Pacific Conference on Problem-Based Learning, Tokyo, May 2006.
123.Hirotsugu Kurobe, Yuki Izawa, Yayoi Fukuhara, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Hiroyuki Azuma, Tetsuya Kitagawa, Toshiaki Tamaki, Toshio Matsumoto, Masaki Ueno, Shuhei Tomita and Masanori Yoshizumi :
T Cell-specific HIF-1α-deficient Mice, but Not ARNT-deficient Mice, Exhibit Exacerbated Inflammation and Vascular Remodeling in Response to Cuff Injury,
American Heart Association 2005 Scientifc Sessions, Dallas, Nov. 2005.
124.Toshiaki Tamaki, Yasuhisa Kanematsu, Yuki Izawa, Hideki Ohnishi, Yuki Motobayashi, Shoji Kagami and Koichiro Tsuchiya :
Chronic oral administration of nitrite restores circulating NO level and improves renal injury in L-NAME treated rats,
38th ASN annual meeting, Philadelphia, Nov. 2005.
125.Keisuke Ishizawa, Rika Sugimoto, Yuki Izawa, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
The inhibitory effect of adiponectin on migration and proliferation induced by PDGF in rat mesangial cells,
38th ASN annual meeting, Philadelphia, Nov. 2005.
126.Maki Shimizu, Shuji Kondo, Maki Urushihara, Masanori Takamatsu, Toshiaki Tamaki and Shoji Kagami :
Reactive Oxygen Species (ROS) is Pivotal Mediator for Glomerular Epithelial-Mesenchymal Transition (EMT) in Experimental Progressive Glomerulonephritis (GN),
38th ASN annual meeting, Philadelphia, Nov. 2005.
127.Hiroyuki Sakakibara, Kaori Ishida, Yuki Izawa, Yuko Minami, Satomi Saito, Yoshichika Kawai, Butterweck Veronika, Toshiaki Tamaki, Yutaka Nakaya and Junji Terao :
Effects of Ginkgo biloba Extract on Rat brain Function,
2nd International Conference on Polyphenols and Health, California Davis, Davis, Oct. 2005.
128.Soichiro Tajima, Koichiro Tsuchiya, Hideki Ohnishi, Yasuhisa Kanematsu, Masanori Yoshizumi, Toshiaki Tamaki, Mason P. Ronald and Yoshiharu Takiguchi :
Immunochemical Dection of Thioredoxin-Derived Radicals Formed by Reaction with Hydrogen Peroxide,
EPR 2005, Columbus, OH, Sep. 2005.
129.Koichiro Tsuchiya, Kaori Akai, Akira Tokumura, Shinji Abe, Toshiaki Tamaki, Yoshiharu Takiguchi and Kenji Fukuzawa :
Oxygen Radicals Photo-induced by Ferric Nitrilotriacetate(FE-NTA) Complex,
EPR 2005, Columbus, OH, Sep. 2005.
130.Hiroyuki Sakakibara, Kaori Ishida, Yuki Izawa, Yuko Minami, Saito Saromi, Yoshichika Kawai, Butterweck Veronika, Toshiaki Tamaki, Yutaka Nakaya and Junji Terao :
Effects of forced swimming stress on rat brain function,
2005 COE International Conference ''Biological Mechanism for Stress Control'', Tokushima, Aug. 2005.
131.Keisuke Ishizawa, Rika Sugimoto, Yuki Izawa, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Adiponectin inhibits PDGF-induced migration and proliferation in rat mesangial cells,
第10回アディポサイエンス研究会シンポジウム(第10回記念国際シンポジウム), Osaka, Aug. 2005.
132.Toshiaki Tamaki, Masumi Okamoto, Yasuhisa Kanematsu, Yuki Izawa, Shoji Kagami, Shuji Kondo, Masanori Yoshizumi and Koichiro Tsuchiya :
Dietary dose of nitrite attenuates L-NAME-induced renal injury in rats,
3rd World Congress of Nephrology, Singapore, Jun. 2005.
133.Masanori Yoshizumi, Keisuke Ishizawa, Yuki Izawa, Chieko Miki, Yoshiko Fujita, Yasuhisa Kanematsu, Koichiro Tsuchiya and Toshiaki Tamaki :
Aldosterone stimulates vascular smooth muscle cell proliferation through big mitogen-activated protein kinase1 activation,
16th scientific meeting of the interamerican society of hypertension, Cancun, Mexico, Apr. 2005.
134.Toshiaki Tamaki, Masumi Okamoto, Yasuhisa Kanematsu, Yuki Izawa, Shoji Kagami, Shuji Kondo, Maki Shimizu, Masanori Yoshizumi and Koichiro Tsuchiya :
Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in rat kidney,
37th ASN annual meeting, St. Louis, MO, Oct. 2004.
135.Shuji Kondo, Maki Shimizu, Koichiro Tsuchiya, Masanori Yoshizumi, Toshiaki Tamaki, Hiroshi Kawachi, Fujio Shimizu, Quinn T Mark, Lambeth J David, Yasuhiro Kuroda and Shoji Kagami :
Add-on the antioxidant, probucol to angiotensin II type I receptor antagonist (ARB) arrests the progressive,
St. Louis, MO, Oct. 2004.
136.Shuji Kondo, M Shimizu, Koichiro Tsuchiya, Masanori Yoshizumi, Toshiaki Tamaki, H Kawachi, F Shimizu, Quinn MT, Lambeth DJ, Yasuhiro Kuroda and Shoji Kagami :
Add-On the antioxidant,probucol to angiotensin 2 Type I receptor antagonist (ARB) arrests the progressive glomerulonephritis (GN) in the rat,
37th Annual meeting of American Society of Nephrology, St. Louis, 2004.
137.Toshiaki Tamaki, K Kirima, Masato Okamoto, S. Kondo, Shoji Kagami, Masanori Yoshizumi and Koichiro Tsuchiya :
Oral nitrite increases the blood oxide and protects L-NAME-induced renal injury in rats,
36th Annual meeting of American Society of Nephrology, San Diego, 2003.

Proceeding of Domestic Conference:

1.Yuya Horinouchi, Yasumasa Ikeda, Hirofumi Hamano, Masaki Imanishi, Keijo Fukushima, Mitsuhiro Goda, Kenshi Takechi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全関連骨格筋萎縮における鉄代謝異常,
第92回日本薬理学会年会, Mar. 2019.
2.Yasumasa Ikeda, Akiho Satoh, Yuya Horinouchi, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron accumulation negatively regulates skeletal muscle myogenesis,
第92回日本薬理学会年会, Mar. 2019.
3.Yuya Horinouchi, Yasumasa Ikeda and Toshiaki Tamaki :
疾患における鉄の意義と治療応用,
第92回日本薬理学会年会 シンポジウム2:必須微量金属研究のパラダイムシフト, Mar. 2019.
4.Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Watanabe, Hirofumi Hamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
マクロファージフェリチン欠損は肥満・糖尿病における脂肪炎症を抑制する,
第48回日本心脈管作動物質学会, Feb. 2019.
5.Yuya Horinouchi, Yasumasa Ikeda and Toshiaki Tamaki :
肥満・糖尿病における鉄制御の意義,
第48回日本心脈管作動物質学会 シンポジウム4:心疾患腎代謝疾患の制御因子としての微量金属栄養素「鉄」の新たな展開, Feb. 2019.
6.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Hirofumi Hamano, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Kenshi Takechi, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
リアルワールドビッグデータを活用した新規腎保護薬の探索,
第28回日本医療薬学会年会, Nov. 2018.
7.井上 陽加, Licht Miyamoto, 服部 真奈, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
亜硝酸塩による脂肪組織への抗肥満的な影響,
第134回日本薬理学会近畿部会, Nov. 2018.
8.Yuya Horinouchi, Yasumasa Ikeda, Hirofumi Hamano, Masaki Imanishi, Keijo Fukushima, Mitsuhiro Goda, Kenshi Takechi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全関連サルコペニアにおける鉄の関与,
第134回日本薬理学会近畿部会, Nov. 2018.
9.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Yuki Izawa-Ishizawa, Hiromichi Fujino and Toshiaki Tamaki :
リアルワールドデータを活用した新規腎保護薬の探索,
第48回日本腎臓学会西部学術大会, Sep. 2018.
10.Yasumasa Ikeda and Toshiaki Tamaki :
シンポジウム1「腎疾患(CKD)の治療と研究の最前線」慢性腎臓病における鉄代謝の意義と治療応用,
第48回日本腎臓学会西部学術大会, Sep. 2018.
11.Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Watanabe, Hirofumi Hamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Yoshito Zamami, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
マクロファージ鉄の肥満・糖尿病における役割 第42回日本鉄バイオサイエンス学会学術集会 2018/9/2 石川県 金沢医科大学病院北辰講堂,
第42回日本鉄バイオサイエンス学会学術集会, Sep. 2018.
12.Koichiro Tsuchiya, Licht Miyamoto, Shuichi Hamano, Yuya Horinouchi, Yasumasa Ikeda, Toshiaki Tamaki and 津田 勝範 :
抗マラリア薬artesunateからの鉄依存活性酸素生成メカニズムの検討,
第71回日本酸化ストレス学会,第18回日本NO学会 合同学術集会, May 2018.
13.Yoshito Zamami, Marin Mitsui, Yuki Izawa-Ishizawa, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Keijo Fukushima, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを活用したベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
日本薬学会第138年会, Mar. 2018.
14.Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いた心肺蘇生後脳症治療薬の探索,
日本薬学会第138年会, Mar. 2018.
15.Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
Factor Xa Inhibitor Exerts a Protective Effect against Renal Injury,
第82回日本循環器学会学術集会, Mar. 2018.
16.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Hirofumi Hamano, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
大規模医療情報データベース解析と基礎研究の融合による新規腎保護薬の探索,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
17.Yuki Izawa-Ishizawa, Yu Kagimoto, Masaki Imanishi, Yusuke Iwata, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
マウス大動脈瘤形成に対するケルセチンの効果,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
18.Masaki Imanishi, Masateru Kondoh, Kyohei Tanaka, Raiki Ikutoh, Yoichi Murai, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Febuxostatの尿酸合成抑制作用とは独立した血管線維化抑制機構の解明,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
19.Kenshi Takechi, Yoshito Zamami, Masaki Imanishi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Toshiaki Tamaki, Keisuke Ishizawa and Hiroaki Yanagawa :
てんかん誘発性精神症状の行動学的解析および治療薬の探索と作用機序の解明,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
20.Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用した心肺停止患者に対するニコランジルの有効性に関する検討,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
21.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
第Xa因子阻害剤の腎保護効果,
第47回日本心脈管作動物質学会, Feb. 2018.
22.Licht Miyamoto, 梅本 果奈, 上島 沙弥香, 友成 奈央実, 土橋 有希, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
食後生じるAMPKの新たな翻訳後修飾を介した代謝制御機構,
心脈管作動物質学会, Feb. 2018.
23.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Yuki Izawa-Ishizawa, Hiromichi Fujino and Toshiaki Tamaki :
医療ビッグデータを活用した腎保護薬の探索,
2017年度 肥満・糖尿病クラスター・ミニリトリート, Feb. 2018.
24.Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
第Xa因子阻害薬の腎保護効果,
第10回 心・血管クラスター・ミニリトリート, 2017.
25.Masahiro Betsushiyo, 村上 圭史, 藤猪 英樹, Katsunori Tsuda, Licht Miyamoto, Koichiro Tsuchiya, Yasumasa Ikeda, Toshiaki Tamaki and Shuichi Hamano :
Actinomyces spp. による硝酸イオンの還元と生理作用の検討,
第41回徳島県医学検査学会, Dec. 2017.
26.Sakiko Hino, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用した薬剤性腎障害に対する予防薬の探索,
西日本医学生学術フォーラム2017, Dec. 2017.
27.Yusuke Iwata, Yuki Izawa-Ishizawa, Yu Kagimoto, Kotoko Suzuki, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
マウス大動脈瘤形成に対するケルセチンの効果,
西日本医学生学術フォーラム2017, Dec. 2017.
28.Yuki Izawa-Ishizawa, Yu Kagimoto, Masaki Imanishi, Yuya Horinouchi, Kotoko Suzuki, Yusuke Iwata, Yoshito Zamami, Kenshi Takechi, Yasumasa Ikeda, Toshiaki Tamaki and Keisuke Ishizawa :
ケルセチンによる動脈硬化性疾患発症に対する予防効果の検討,
第27回日本循環薬理学会, Dec. 2017.
29.Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を用いて新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究,
第38回日本臨床薬理学会学術総会, Dec. 2017.
30.Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
臨床薬理学集中講座修了後の研究活動∼大規模医療情報を活用したドラッグリポジショニング研究を中心に∼,
第38回日本臨床薬理学会学術総会 臨床薬理学集中講座フォローアップ・セミナー, Dec. 2017.
31.Hiroaki Watanabe, Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
肥満・糖尿病におけるマクロファージ鉄制御機構の検討,
第132回日本薬理学会近畿部会, Nov. 2017.
32.Takahiro Niimura, Yoshito Zamami, 小山 敏広, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニングを切り口とした心肺蘇生後症候群治療薬の探索研究,
第27回日本医療薬学会年会, Nov. 2017.
33.Yoshito Zamami, 小山 敏広, Yuki Izawa-Ishizawa, Takahiro Niimura, Masaki Imanishi, Kenshi Takechi, Yuya Horinouchi, 桐野 靖, 中村 敏己, 寺岡 和彦, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用して心肺停止患者の生存率向上を志向したドラッグリポジショニング研究,
第27回日本医療薬学会年会, Nov. 2017.
34.Marin Mitsui, Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを基にしたベバシズマブと相互作用を起こす薬剤の探索研究,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
35.Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
心肺停止患者の予後に与えるニコランジルの影響-大規模レセプト情報を用いた検討,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
36.Shiori Urushizaki, Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用して新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
37.Yu Kagimoto, Yuki Izawa-Ishizawa, Mayuko Hosohka, Naoko Saito, Kotoko Suzuki, Masaki Imanishi, Yuya Horinouchi, Yoshito Zamami, Kenshi Takechi, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
急性大動脈解離易発症マウスにおけるquercetinの効果,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
38.Kyohei Tanaka, Masaki Imanishi, Masateru Kondoh, Raiki Ikutoh, Yoichi Murai, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
フェブキソスタットの尿酸合成抑制剤作用とは独立した血管線維化抑制作用の検討,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
39.Hiroaki Watanabe, Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
肥満・糖尿病におけるマクロファージ鉄の役割の検討,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
40.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎臓病における尿毒素蓄積によるヘプシジン制御と鉄代謝破綻のメカニズムの解明,
第41回日本鉄バイオサイエンス学会学術集会, Sep. 2017.
41.Yasumasa Ikeda, Yuya Horinouchi, Hirofumi Hamano, 平山 祐, Seiji Kishi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Ken-ichi Aihara, Hideko Nagasawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄摂取制限による尿細管間質障害の抑制効果の検討,
第41回日本鉄バイオサイエンス学会学術集会, Sep. 2017.
42.Licht Miyamoto, Kana Umemoto, Sayaka Ueshima, Naomi Tomonari, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
食後のエネルギー代謝調節を担うAMPK活性制御機構,
次世代を担う創薬医療薬理シンポジウム2017, Aug. 2017.
43.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全における尿毒素蓄積はヘプシジンを介した鉄代謝恒常性破綻に関与する,
大阪市大フォーラム, Aug. 2017.
44.Yoshito Zamami, Yuki Izawa-Ishizawa, 桐野 靖, Marin Mitsui, Shiori Urushizaki, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを切り口としたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム, Aug. 2017.
45.Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
心肺蘇生後症候群治療薬の開発を目的としたドラッグリポジショニング研究-大規模医療情報を活用した検討-,
第255回 徳島医学会学術集会, Aug. 2017.
46.Yoshito Zamami, Yuki Izawa-Ishizawa, 桐野 靖, Marin Mitsui, Shiori Urushizaki, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを切り口としたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム, Jul. 2017.
47.Yuya Horinouchi, Yasumasa Ikeda, Masaki Imanishi, Yoshito Zamami, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
経口FXa阻害剤の腎線維化抑制効果,
医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム, Jul. 2017.
48.Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
第Xa因子阻害剤は腎間質線維化を抑制する,
第131回 日本薬理学会近畿部会, Jun. 2017.
49.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
インドキシル硫酸蓄積はヘプシジン制御を介して鉄代謝恒常性破綻に関与する,
第131回 日本薬理学会近畿部会, Jun. 2017.
50.Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
Inhibitory effect of dietary iron restriction on albumin-induced renal tubulointerstitial injury,
第60回日本腎臓学会学術総会, May 2017.
51.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
インドキシル硫酸はヘプシジンを介した鉄代謝異常に関与する,
第60回日本腎臓学会学術総会, May 2017.
52.Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
FXa阻害剤は腎間質線維化を抑制する,
第60回日本腎臓学会学術総会, May 2017.
53.Licht Miyamoto, Aihara Haruna, Xu Wenting, Jin Meina, Tomida Yosuke, Yamaoka Tomomi, Tanaka Naonobu, Yasumasa Ikeda, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
A limonene-derivative purified from Sudachi peel upregulates sirt1 and improves lipid /glucose metabolism in HFD-fed mice.,
第60回日本糖尿病学会, May 2017.
54.Marin Mitsui, Yoshito Zamami, Yuki Izawa-Ishizawa, Shiori Urushizaki, 桐野 靖, Kazuhito Saike, Hiroshi Moriguchi, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを基にしたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
日本薬学会 第137年会, Mar. 2017.
55.Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
FXa 阻害剤の片側尿管結紮モデルマウスにおける腎間質線維化抑制作用,
日本薬学会 第137年会, Mar. 2017.
56.Raiki Ikutoh, Masaki Imanishi, Kyohei Tanaka, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
アンジオテンシンII 誘発性血管リモデリングに対するキサンチンオキシダーゼ阻害剤の影響,
日本薬学会 第137年会, Mar. 2017.
57.Yasumasa Ikeda and Toshiaki Tamaki :
Excess iron on the risk of tissue injury,
第90回日本薬理学会年会, Mar. 2017.
58.Yasumasa Ikeda and Toshiaki Tamaki :
Excess iron action on risk of tissue injury,
第90回日本薬理学会年会 年会企画ナノシンポジウム 「機能性食品における薬理学」, Mar. 2017.
59.Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Factor Xa inhibitor attenuates renal fibrosis in mice with unilateral ureteral obstruction,
第90回日本薬理学会年会, Mar. 2017.
60.Masaki Imanishi, Kyohei Tanaka, Raiki Ikuto, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Febuxostat suppresses angiotensin II-induced aortic fibrosis,
第90回日本薬理学会年会, Mar. 2017.
61.Masaki Imanishi, 田中 恭平, 生藤 来希, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
フェブキソスタットはアンジオテンシンII誘発性大動脈繊維化を抑制する,
第90回日本薬理学会年会(長崎), Mar. 2017.
62.Yuki Izawa-Ishizawa, Mayuko Hosooka, Naoko Saito, Masaki Imanishi, Yuya Horinouchi, Yoshito Zamami, Kenshi Takechi, Yasumasa Ikeda, Koichiro Tsuchiya, Keisuke Ishizawa and Toshiaki Tamaki :
The effect of quercetin on the aortic dissection onset via its endothelial protective effect in mice,
第90回日本薬理学会年会, Mar. 2017.
63.Licht Miyamoto, Goki Tomokawa, Yuki Matsuda, Moe Yamane, Mana Hattori, Reina Oonishi, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
Significance of central regulation in physical exercise-induced metabolic alterations in skeletal muscles,
The 90th Annual Meeting of The Japanese Pharmacology Society, Mar. 2017.
64.Koichiro Tsuchiya, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Yuya Horinouchi, Licht Miyamoto and Toshiaki Tamaki :
鉄ストレスと代謝性疾患-鉄ストレスによる疾患と,鉄ストレスによる治療,
日本薬学会第137年会, Mar. 2017.
65.Yoshito Zamami, Yuki Izawa-Ishizawa, 桐野 靖, 三井 茉綸, 漆崎 汐里, 斉家 和仁, 森口 浩史, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを切り口としたベバシズマブと相互作用を起こす薬剤の探索研究,
第46回日本心脈管作動物質学会年会, Feb. 2017.
66.Masaki Imanishi, 田中 恭平, 生藤 来希, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Angiotensin II誘発性血管リモデリングに対するfebuxostatの効果,
第46回日本心脈管作動物質学会, Feb. 2017.
67.Licht Miyamoto, 友川 剛己, 松田 裕樹, 山根 萌, 服部 真奈, 大西 伶奈, Yasumasa Ikeda, Toshiaki Tamaki, Koichiro Tsuchiya and Koichiro Tsuchiya :
身体運動時に生じる骨格筋代謝状態の変化における,中枢を介した調節機構の意義,
第46回日本心脈管作動物質学会, Feb. 2017.
68.Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Akiho Satoh, Keisuke Oshima, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全における尿毒素蓄積が生体内鉄代謝に与える影響の検討,
第46回日本心脈管作動物質学会, Feb. 2017.
69.Yuki Izawa-Ishizawa, 細岡 真由子, 斎藤 尚子, 鍵本 優有, Masaki Imanishi, Yoshito Zamami, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ケルセチンによるマウス大動脈解離発症予防効果の検討,
第46回日本心脈管作動物質学会年会, Feb. 2017.
70.友川 剛己, Licht Miyamoto, 松田 裕樹, 山根 萌, 服部 真奈, 大西 怜奈, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
水泳運動負荷時に生じる骨格筋AMPK活性化の新たなメカニズム,第46回日本心脈管作動物質学会年会,
Feb. 2017.
71.Yumi Kangawa, Chiharu Fukue, Katsunori Tsuda, Licht Miyamoto, Koichiro Tsuchiya, Yasumasa Ikeda, Toshiaki Tamaki and Shuichi Hamano :
Artesunateによる細胞傷害発現機序の解明1,
第40回 徳島県医学検査学会, Dec. 2016.
72.Chiharu Fukue, Yumi Kangawa, Katsunori Tsuda, Licht Miyamoto, Koichiro Tsuchiya, Yasumasa Ikeda, Toshiaki Tamaki and Shuichi Hamano :
Artesunateによる細胞傷害発現機序の解明2,
第40回 徳島県医学検査学会, Dec. 2016.
73.Masaki Imanishi, 松永 慎司, Keisuke Ishizawa, Toshiaki Tamaki and Shuhei Tomita :
大動脈瘤形成における平滑筋由来HIF-1αの役割,
第26回日本循環薬理学会, Dec. 2016.
74.Yuki Izawa-Ishizawa, Yutaka Fukunaga, 西良 恵理子, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya, Ichiro Hashimoto and Toshiaki Tamaki :
ニトロソニフェジピンは虚血性皮弁モデルにおいて皮弁壊死を抑制する,
第26回日本循環薬理学会, Dec. 2016.
75.Yoshitaka Kihira, 岸渕 麗奈, Kunihisa Yamaguchi, 藤村 よしの, 佐藤 英治, Toshiaki Tamaki and Shuhei Tomita :
腎虚血再灌流障害におけるグルタチオン分解酵素 CHAC1 の役割,
第130回日本薬理学会近畿部会, Nov. 2016.
76.高橋 梨恵, Licht Miyamoto, 友川 剛己, 宮武 由実子, Hiroshi Sakaue, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
脳内グリコーゲンによる代謝調節効果の検討,
第130回日本薬理学会近畿部会, Nov. 2016.
77.福田 恵介, Licht Miyamoto, 高橋 梨恵, Toshiaki Tamaki, Yasumasa Ikeda and Koichiro Tsuchiya :
スダチ果皮芳香成分が糖脂質代謝に与える影響,
第130回日本薬理学会近畿部会, Nov. 2016.
78.細岡 真由子, Yuki Izawa-Ishizawa, 斎藤 尚子, Masaki Imanishi, Yoshito Zamami, Licht Miyamoto, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
Quercetin による血管内皮細胞保護効果の検討,
第130回日本薬理学会近畿部会, Nov. 2016.
79.Akiho Satoh, Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Mizuki Imao, Hiroaki Watanabe, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
鉄欠乏が骨格筋に与える作用の検討,
第55回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2016.
80.Yutaka Fukunaga, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Ichiro Hashimoto :
虚血性皮弁壊死モデルにおける抗酸化薬ニトロソニフェジピンの壊死抑制効果,
第25回日本形成外科学会基礎学術集会, Sep. 2016.
81.三井 茉綸, Yoshito Zamami, 漆崎 汐里, 斉家 和仁, 森口 浩史, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニングを切り口としたベバシズマブ誘発高血圧に対する予防薬の探索研究,
第27回霧島神経薬理フォーラム(福岡), Aug. 2016.
82.Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, 田淵 正樹, Toshiaki Tamaki and Keisuke Ishizawa :
脳卒中後の神経症状増悪に対するニトロソニフェジピンの効果,
第46回日本神経精神薬理学会年会( ソウル), Jul. 2016.
83.Licht Miyamoto, 秦野 彩, 竹之熊 和也, 土橋 有希, 矢野 友章, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
速効型インスリン分泌促進薬とSGLT2阻害薬の併用による薬効の検討,
第129回日本薬理学会近畿部会, Jun. 2016.
84.Yuki Izawa-Ishizawa, 細岡 真由子, 斎藤 尚子, Yuya Horinouchi, Masaki Imanishi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ケルセチン代謝産物Q3GAの血管内皮膚細胞に対する短期及び長期効果の検討,
第129回日薬理学会学会近畿部会( 広島), Jun. 2016.
85.Yasumasa Ikeda, 佐藤 明穂, Yuya Horinouchi, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
骨格筋分化における鉄の役割,
第129回日薬理学会学会近畿部会 (広島), Jun. 2016.
86.Yasumasa Ikeda, Keisuke Oshima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄は低酸素誘導因子を抑制してエリスロポエチン発現を低下させる,
第59回日本腎臓学会学術総会, Jun. 2016.
87.Licht Miyamoto, 粟飯原 遥菜, 許 文婷, 靳 美娜, 冨田 洋輔, 山岡 朋美, Naonobu Tanaka, Yasumasa Ikeda, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
スダチ果皮における抗メタボリックシンドローム作用を有する物質の同定,
日本薬学会第136年会(横浜), Mar. 2016.
88.細岡 真由子, Yuki Izawa-Ishizawa, 斎藤 尚子, Licht Miyamoto, Masaki Imanishi, Yoshito Zamami, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
ケルセチン生体内代謝産物 quercetin -3-O-β-Dglucuronideによる血管内皮細胞保護効果,
日本薬学会第136年会(横浜), Mar. 2016.
89.鍵本 優有, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
無機リン刺激による血管平滑筋細胞石灰化におけるrho-kinase 及び cyclophilinA の関与,
日本薬学会第136年会(横浜), Mar. 2016.
90.Hiroaki Watanabe, Yasumasa Ikeda, Hirofumi Hamano, Akiho Satoh, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
慢性腎臓病におけるヘプシジン制御メカニズムの検討,
日本薬学会第136年会(横浜), Mar. 2016.
91.佐藤 明穂, Yasumasa Ikeda, Yuya Horinouchi, 濱野 裕章, 今尾 瑞季, 渡邉 大晃, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Toshiaki Tamaki, Licht Miyamoto and Koichiro Tsuchiya :
鉄過剰による骨格筋分化抑制作用の解明,
日本薬学会第136年会(横浜), Mar. 2016.
92.Yasumasa Ikeda, Keisuke Oshima, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron Supplementation Suppressed Erythropoietin Expression through HIF-dependent Pathway,
The 80th Annual Scientific Meeting of the Japanese Circulation Society, Mar. 2016.
93.太田 和馬, Yoshitaka Kihira, 岸渕 麗奈, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
電位依存性カリウムチャネルKv2.2は腎虚血再灌流障害の軽減に関与する,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
94.岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
HIF-1aはアポトーシス制御因子Bcl-2及びCHAC1の発現制御を介して腎虚血再灌流障害からの回復に関与する,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
95.斎藤 尚子, Yuki Izawa-Ishizawa, 細岡 真由子, Yoshitaka Kihira, Masaki Imanishi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ケルセチン代謝物Q3GAによる血管内皮細胞保護効果の検討,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
96.青木 友里, Yuki Izawa-Ishizawa, 高田 真衣, 田渕 正樹, Masaki Imanishi, Yoshito Zamami, 福永 豊, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya, Keisuke Ishizawa and Toshiaki Tamaki :
神経突起伸長および脳卒中後神経症状に対するニトロソニフェジピンの効果,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
97.大島 啓亮, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄のエリスロポエチン発現への影響の検討,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
98.佐藤 明穂, Yasumasa Ikeda, Yuya Horinouchi, 濱野 裕章, 今尾 瑞季, 渡邉 大晃, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄欠乏に伴う骨格筋萎縮メカニズム,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
99.Licht Miyamoto, Haruna Aihara, Wenting Xu, Meina Jin, Yosuke Tomida, Tomomi Yamaoka, Naonobu Tanaka, Yasumasa Ikeda, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
Identification of an active compound on lipid metabolism from Sudachi peel,
薬理学会(パシフィコ), Mar. 2016.
100.Licht Miyamoto, 粟飯原 遥菜, Xu Wenting, Jin Meina, 冨田 洋輔, 山岡 朋美, Naonobu Tanaka, Yasumasa Ikeda, Toshiaki Tamaki, Yoshiki Kashiwada and Koichiro Tsuchiya :
脂質低下作用を有するスダチ果皮由来化合物の薬理作用,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
101.濱野 裕章, Yasumasa Ikeda, 渡邉 大晃, 佐藤 明穂, 大島 啓亮, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
尿毒素は慢性腎不全におけるヘプシジン発現に関与する,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
102.Masaki Imanishi, 井口 道代, 冨田 紀子, 松永 慎司, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1 in smooth muscle cells protects against aortic aneurysm formation via elastin-fiber formation,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
103.Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshitaka Kihira, Licht Miyamoto, Yoshito Zamami, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Development of endothelial dysfunction-induced aortic dissection model and search for a preventive strategy,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
104.Masaki Imanishi, Keisuke Ishizawa, 小原 佑介, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニフェジピン光分解産物による血管リモデリング抑制効果,
第252回 徳島医学会学術集会(平成27年度冬期), Feb. 2016.
105.Masaki Imanishi, 井口 道代, 冨田 紀子, 松永 慎司, Toshiaki Tamaki and Shuhei Tomita :
平滑筋由来HIF-1 αによる弾性繊維構築を介した大動脈瘤形成抑制メカニズムの検討,
第45回日本心脈管作動物質学会, Feb. 2016.
106.Keisuke Oshima, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄のエリスロポエチン発現への影響の検討,
第45回日本心脈管作動物質学会, Feb. 2016.
107.Masaki Imanishi, Keisuke Ishizawa, 小原 佑介, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンによる抗大動脈瘤機序の検討,
第45回日本心脈管作動物質学会, Feb. 2016.
108.Yuki Izawa-Ishizawa, Keisuke Ishizawa, 鍵本 優有, 斎藤 尚子, 高田 真衣, Yoshitaka Kihira, Masaki Imanishi, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
高リン刺激は血管平滑筋細胞においてrho-kinase-cyclophilin A経路を活性化させる,
第45回日本心脈管作動物質学会, Feb. 2016.
109.Asuka Shigetomi, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Shuichi Hamano :
LED灯によるビリルビン光分解の検討,
徳島検査医学会, Dec. 2015.
110.Yasumasa Ikeda and Toshiaki Tamaki :
臓器障害における生体内鉄代謝の意義と鉄除去による病態改善効果,
心血管代謝週間(CVMW)(第19回日本心血管内分泌代謝学会学術総会) シンポジウム, Dec. 2015.
111.Yasumasa Ikeda, 濱野 裕章, 渡邉 大晃, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎臓病におけるヘプシジン制御メカニズムの検討,
第25回日本循環薬理学会, Dec. 2015.
112.Yuki Izawa-Ishizawa, Keisuke Ishizawa, 高田 真衣, 田渕 正樹, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの 生命予後を改善する,
第25回日本循環薬理学会, Dec. 2015.
113.斎藤 尚子, Yuki Izawa-Ishizawa, Keisuke Ishizawa, 戸谷 紘基, Masaki Imanishi, 鍵本 優有, 細岡 真由子, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈解離発症における内皮障害の関与,
第25回日本循環薬理学会, Dec. 2015.
114.Hirofumi Hamano, Yasumasa Ikeda, Yuya Horinouchi, Akiho Satoh, Hiroaki Watanabe, Keisuke Oshima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全における尿毒素によるヘプシジン制御機構,
第128回日本薬理学会近畿部会, Nov. 2015.
115.今尾 瑞季, Yasumasa Ikeda, 佐藤 明穂, 濱野 裕章, Yuya Horinouchi, Licht Miyamoto, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
鉄蓄積によって引き起こされる骨格筋萎縮のメカニズム,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2015.
116.高田 真衣, Keisuke Ishizawa, 田渕 正樹, Yuki Izawa-Ishizawa, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
悪性脳卒中易発性高血圧自然発症ラットの神経症状に対するニトロソニフェジピンの効果,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2015.
117.戸谷 紘基, Keisuke Ishizawa, Yuki Izawa-Ishizawa, 細岡 真由子, 鍵本 優有, 斎藤 尚子, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
大動脈解離発症における内皮障害の関与の検討,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2015.
118.Yasumasa Ikeda, 佐藤 明穂, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄欠乏は骨格筋量減少の原因となる,
第39回日本鉄バイオサイエンス学会学術集会, Aug. 2015.
119.Ariunzaya Burentogtokh, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
YC1 increased adiponectin expression in 3T3-L1 adipocytes,
次世代を担う創薬・医療薬理シンポジウム2015, Aug. 2015.
120.Yuki Izawa-Ishizawa, Keisuke Ishizawa, 大越 瑞穂, 土肥 紗希子, Yoshitaka Kihira, Yasumasa Ikeda and Toshiaki Tamaki :
血管石灰化シグナルにおけるRhoキナーゼおよびサイクロフィリンAの関与,
第47回日本動脈硬化学会総会・学術集会, Jul. 2015.
121.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masashi Akaike, Toshiaki Tamaki and Toshio Matsumoto :
心血管疾患における男性ホルモンの意義,
第15回日本抗加齢医学会総会 シンポジウム「知って得するテストステロンアップデート」, May 2015.
122.Yasumasa Ikeda, Kanai Yusuke, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Bilirubin Promotes Ischemic-Induced Revascularization through Akt-eNOS Pathway,
第79回 日本循環器学会学術集会, Apr. 2015.
123.Yoshitaka Kihira, 岸渕 麗奈, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
腎虚血再灌流障害において低酸素誘導因子が制御する因子の探索,
日本薬学会第135年会(神戸), Mar. 2015.
124.Mai Takata, Keisuke Ishizawa, 田渕 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
悪性脳卒中易発性高血圧自然発症ラットに対するニトロソニフェジピンの効果,
日本薬学会第135年会(神戸), Mar. 2015.
125.Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ビリルビンは虚血後血管新生を促進する,
第88回 日本薬理学会年会(愛知), Mar. 2015.
126.Yuki Izawa-Ishizawa, Keisuke Ishizawa, 田渕 正樹, Mai Takata, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの生存期間を延長させる,
第88回 日本薬理学会年会(愛知), Mar. 2015.
127.Hiroki Toya, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Yusuke Kohara, Tomoko Nagao, 今西 正樹, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈解離発症における血管内皮機能障害の関与,
第88回 日本薬理学会年会(愛知), Mar. 2015.
128.岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible factor-1 participates in induction of apoptosis in renal reperfusion injury,
第88回 日本薬理学会年会(愛知), Mar. 2015.
129.今西 正樹, 井口 道代, 冨田 紀子, ツナピ パナギオタ, 松永 慎司, Keisuke Ishizawa, Toshiaki Tamaki and Shuhei Tomita :
血管リモデリングにおける平滑筋由来hypoxia-inducible factor-1αの役割,
第88回 日本薬理学会年会(愛知), Mar. 2015.
130.Mizuho Ogoshi, Yuki Izawa-Ishizawa, Sakiko Doi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管平滑筋細胞において無機リンによる石灰化シグナルにはRho-kinaseおよびcyclophilin Aが関与する,
第88回 日本薬理学会年会(愛知), Mar. 2015.
131.Burentogtokh Ariunzaya, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia decreases glucagon-like peptide-1 secretion from glutag cell lines,
第88回 日本薬理学会年会(愛知), Mar. 2015.
132.Yasumasa Ikeda, 金井 佑亮, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ビリルビンの血管新生促進作用の検討,
第44回 日本心脈管作動物質学会, Feb. 2015.
133.Yuri Morimoto, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Shuichi Hamano :
セスキテルペンラクトン誘導体の鉄依存細胞障害機構の解明,
第38回 徳島県医学検査学会, Dec. 2014.
134.Yasumasa Ikeda, 金井 佑亮, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ビリルビンは血管内皮細胞を活性化させて,虚血後血管新生を促進する,
第24回 循環薬理学会, Dec. 2014.
135.Yuki Izawa-Ishizawa, Keisuke Ishizawa, 長尾 朋子, 戸谷 紘基, 小原 佑介, 細岡 真由子, 高田 真衣, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
新規薬剤誘発性大動脈解離モデルを用いたスタチンの効果の検討,
第24回 循環薬理学会, Dec. 2014.
136.今西 正樹, Masaki Murakami, Yusaku Maeda, 冨田 紀子, Tsounapi Panagiota, 松永 慎司, Toshiaki Tamaki and Shuhei Tomita :
血管傷害モデルに伴う血管リモデリング形成に対する骨髄由来細胞のHIF-1αの関与,
第67回日本薬理学会西南部会, Nov. 2014.
137.今西 正樹, 井口 道代, 冨田 紀子, Tsounapi Panagiota, 松永 慎司, Toshiaki Tamaki and Shuhei Tomita :
血管リモデリングにおける平滑筋由来HIF-1αの作用,
第12回 がんとハイポキシア研究会, Nov. 2014.
138.岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
低酸素誘導因子の機能不全は腎虚血再灌流障害からの回復を阻害する,
第36回 生体膜と薬物の相互作用シンポジウム, Nov. 2014.
139.Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
高脂肪食誘発肥満に対する脂肪特異的低酸素誘導因子欠損の影響,
第36回 生体膜と薬物の相互作用シンポジウム, Nov. 2014.
140.山根 萌, Licht Miyamoto, 冨田 洋輔, 竹之熊 和也, 川崎 彩, 山岡 朋美, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
ヒト腎糸球体内皮細胞における亜硝酸塩によるAMPK-eNOS活性化経路の検討,
第53回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Nov. 2014.
141.長尾 朋子, Keisuke Ishizawa, 戸谷 紘基, 小原 佑介, 今西 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
HMG-CoA 還元酵素阻害薬の大動脈解離に対する効果,
第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2014.
142.小原 佑介, Keisuke Ishizawa, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, 今西 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈瘤形成に対する新規抗酸化薬の効果,
第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2014.
143.山根 萌, Licht Miyamoto, 冨田 洋輔, 竹之熊 和也, 川崎 彩, 山岡 朋美, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
亜硝酸塩による AMPK-eNOS 経路活性化,
第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2014.
144.岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
低酸素誘導因子の腎虚血再灌流障害に対する役割,
第126回日本薬理学会近畿部会, Oct. 2014.
145.長尾 朋子, Keisuke Ishizawa, 戸谷 紘基, 小原 佑介, 今西 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈解離に対するピタバスタチンの効果,
第126回日本薬理学会近畿部会, Oct. 2014.
146.山根 萌, Licht Miyamoto, 冨田 洋輔, 竹之熊 和也, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
ヒト腎糸球体内皮細胞におけるAMPK-eNOS経路の活性化,
第126回日本薬理学会近畿部会, Oct. 2014.
147.Yasumasa Ikeda, 今尾 瑞季, 佐藤 明穂, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄による骨格筋萎縮メカニズムの検討,
日本鉄バイオサイエンス学会 第38回学術集会, Sep. 2014.
148.小原 佑介, Keisuke Ishizawa, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは大動脈瘤の形成を抑制する,
次世代を担う創薬・医療薬理シンポジウム 2014, Aug. 2014.
149.戸谷 紘基, Keisuke Ishizawa, 小原 佑介, 長尾 朋子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管内皮障害を介する新規大動脈解離モデルの作製,
次世代を担う創薬・医療薬理シンポジウム 2014, Aug. 2014.
150.山根 萌, Licht Miyamoto, 冨田 洋輔, 竹之熊 和也, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
亜硝酸塩による AMPK-eNOS 経路活性化,
次世代を担う創薬・医療薬理シンポジウム 2014, Aug. 2014.
151.山根 萌, Licht Miyamoto, 冨田 洋輔, 竹之熊 和也, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
亜硝酸塩によるAMPK-eNOS経路活性化,
生体機能と創薬シンポジウム 2014, Aug. 2014.
152.矢野 友章, Licht Miyamoto, 竹之熊 和也, 福田 恵介, 津田 勝範, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
食事による血中NOレベル変動の検討,
第249回徳島医学会, Jul. 2014.
153.小原 佑介, Keisuke Ishizawa, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
薬剤誘導性大動脈瘤モデルに対するニトロソニフェジピンの効果,
第125回日本薬理学会近畿部会, Jun. 2014.
154.Yasumasa Ikeda, 田島 壮一郎, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
アンジオテンシンIIは鉄吸収制御と生体内鉄分布変化に関与する,
第125回日本薬理学会近畿部会, Jun. 2014.
155.今西 正樹, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya and Toshiaki Tamaki :
血管リモデリングにおける低酸素誘導因子HIF-1αの役割,
日本薬学会第134年会, Mar. 2014.
156.Yoshitaka Kihira, Ariunzaya BURENTOGTOKH, Mari Itoh, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
腸管L細胞のグルカゴン様ペプチド-1分泌に対する低酸素の影響,
日本薬学会第134年会, Mar. 2014.
157.Keisuke Ishizawa, Yuki Izawa-Ishizawa, Noriko Yamano, 布 あさ美, 今西 正樹, 櫻田 巧, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates the progression of renal disease associated with endothelial dysfunction independently of eNOS,
第87回日本薬理学会年会, Mar. 2014.
158.Licht Miyamoto, Megumi Yamane, Yohsuke Tomida, Kazuya Takenokuma, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
亜硝酸塩による腎保護作用および糖脂質代謝改善作用におけるAMPKの意義,
第87回日本薬理学会年会, Mar. 2014.
159.Mizuki Imao, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The mechanism of sj=keletal muscle atroph induced by iron,
第87回日本薬理学会年会, Mar. 2014.
160.Yuya Horinouchi, Summers A. Fiona, Ehrenshaft Marilyn, Koichiro Tsuchiya, Toshiaki Tamaki and Mason P. Ronald :
Investigating free radical generation in HepG2 cells induced by aromatic amine compounds using immuno-spin trapping,
第87回日本薬理学会年会, Mar. 2014.
161.Yuki Izawa-Ishizawa, Le Nhat-Tu, 竹井 雄一郎, Heo Kyung-Sun, Lee Hakjoo, Smrcka Alan, Miller Benjamin, Ko Kyung-Ae, Ture Sara, Morrell Craig, 藤原 敬己, Masashi Akaike, Toshiaki Tamaki and 阿部 純一 :
Anti-inflammatory effects of statins and anti-malarial agents via endothelial ERK5 activation,
第87回日本薬理学会年会, Mar. 2014.
162.井口 道代, 冨田 紀子, 今西 正樹, Hirotsugu Kurobe, 菅澤 典子, 佐藤 至, 松永 慎司, Toshiaki Tamaki and Shuhei Tomita :
The role of smooth muscle cells specic HIF-1Į in pulmonary hypertension in mice,
第87回日本薬理学会年会, Mar. 2014.
163.Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
アンジオテンシンIIは十二指腸鉄輸送体発現とマクロファージ鉄量を増加させる,
第43回日本心脈管作動物質学会, Feb. 2014.
164.山脇 早穂, 佐藤 佑太, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuichi Hamano :
リチウム定量にあたえる共存物質の影響,
第37回徳島県医学検査学会, Dec. 2013.
165.佐藤 佑太, 山脇 早穂, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuichi Hamano :
セスキテルペンラクトン誘導体の鉄依存ラジカル生成過程の解明,
第37回徳島県医学検査学会, Dec. 2013.
166.Masaki Imanishi, Shuhei Tomita, Hirotsugu Kurobe, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
薬剤誘導性大動脈瘤モデルにおける平滑筋由来hypoxia-inducible factor-1αの役割,
第23回日本循環薬理学会, Dec. 2013.
167.Atsushi Morimoto, Shuhei Tomita, Yoshitaka Kihira, Yasumasa Ikeda, Ichiro Hashimoto, 高久 暢, Hideki Nakanishi and Toshiaki Tamaki :
血管内皮細胞特異的HIF-2α強制発現マウスを用いた虚血皮弁モデルの作製と検討,
第22回 日本形成外科学会基礎学術集会, Nov. 2013.
168.Yoshitaka Kihira, Shuhei Tomita, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
肥満に伴う脂肪組織炎症に対する低酸素誘導因子の役割,
第124回日本薬理学会近畿部会, Nov. 2013.
169.布 あさ美, Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, 櫻田 巧, Masaki Imanishi, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
ニトロソニフェジピンは血管内皮機能を改善することで糖尿病性腎症の進展を抑制する,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
170.Yuta Suzuki, Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
平滑筋由来HIF-1 αがアンジオテンシンII 誘発血管リモデリングに関与するメカニズム,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
171.Masaki Murakami, Yusaku Maeda, Shuhei Tomita, Masaki Imanishi, Yoshitaka Kihira, Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管傷害モデルに伴う血管リモデリングにおける骨髄由来細胞のHIF1 αの役割,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
172.Mariko Miyake, Yoshitaka Kihira, Shuhei Tomita, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
脂肪細胞の低酸素誘導因子欠損による耐糖能改善メカニズムの解析,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
173.Yasumasa Ikeda, 田島 壮一郎, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
フェリチンの炎症惹起作用,
第37回日本鉄バイオサイエンス学会, Sep. 2013.
174.Masaki Murakami, Shuhei Tomita, Yusaku Maeda, Masaki Imanishi, Noriko Yamano, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する,
次世代を担う創薬・医療薬理シンポジウム2013, Aug. 2013.
175.Noriko Yamano, Keisuke Ishizawa, 小堀 浩幸, Maki Urushihara, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病性腎症における腎内局所アンジオテンシノーゲンに対するニトロソニフェジピンの効果,
第123回日本薬理学会近畿部会, Jul. 2013.
176.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に関与するメカニズムの解析,
第34回日本炎症・再生医学会, Jul. 2013.
177.Yuya Horinouchi, Fiona A. SUMMERS, Marilyn EHRENSHAFT, Toshiaki Tamaki and Ronald P. MASON :
フリーラジカル直接検出法immuno-spin trapping, In-Cell Westernとconfocal microscopyを用いた環境汚染物質の細胞毒性評価,
第40回日本毒性学会学術年会, Jun. 2013.
178.Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, 櫻田 巧, Masaki Imanishi, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは血管内皮保護作用を示して糖尿病性腎症進展を抑制する,
第56回日本腎臓学会学術総会, May 2013.
179.Masaki Imanishi, Keisuke Ishizawa, Takumi Sakurada, Yuki Izawa-Ishizawa, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
酸化ストレスに起因する心腎血管障害の克服を目指す新規治療薬開発,
日本薬学会第133年会, Mar. 2013.
180.Koichiro Tsuchiya, Yasumasa Ikeda, 田島 壮一郎, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Licht Miyamoto, Noriko Yamano and Toshiaki Tamaki :
糖尿病に対する鉄の関与とキレート療法,
日本薬学会第133年会, Mar. 2013.
181.Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible factor-1a; in vascular smooth muscle cells contributes to AT1 receptor expression in angiotensin II-induced vascular remodeling in mice,
第86回日本薬理学会年会, Mar. 2013.
182.Mari Itoh, Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Secretion of glucagon-like peptide-1 from Intestinal L cell in hypoxia,
第86回日本薬理学会年会, Mar. 2013.
183.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Yuya Horinouchi, Takumi Sakurada, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Kazuyoshi Kawazoe, Kazuo Minakuchi and Toshiaki Tamaki :
The influence of angiotensin II on duodenal iron absorption,
第86回日本薬理学会年会, Mar. 2013.
184.Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Bovine lactoferrin stimulated angiogenesis in response to ischemic hindlimb,
第86回日本薬理学会年会, Mar. 2013.
185.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakiko Doi, Masaki Imanishi, Takumi Sakurada, Noriko Yamano, Yusuke Kohara, Tomoko Nagao, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Y-27632, a rho-kinase inhibitor, inhibits inorganic phosphate-induced ERK1/2 phosphorylation and ALP activity in vascular smooth muscle cells,
第86回日本薬理学会年会, Mar. 2013.
186.Iori Ohzono, Yasumasa Ikeda, Souichirou Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The Effects of Iron chelatoion against Renal Fibrosis in Unilateral Ureteral Obstruction Mice Model,
第86回日本薬理学会年会, Mar. 2013.
187.Yoji Hoshina, Yoshitaka Kihira, Shuhei Tomita, Mariko Miyake, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Adipocyte-specific hypoxia-inducible factor-1alpha knockout stimulated GLP-1 and insulin secretions in mice,
第86回日本薬理学会年会, Mar. 2013.
188.Noriko Yamano, Keisuke Ishizawa, Shoko Fujii, Asami Nuno, Masaki Imanishi, Takumi Sakurada, Yuta Suzuki, Furi Endo, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Effects of nitrosonifedipine on the diabetic nephropathy with the endothelial dysfunction,
第86回日本薬理学会年会, Mar. 2013.
189.Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Low Iron Diet Limits Development of Diabetic Nephropathy In db/db Mice,
第77回日本循環器学会学術集会, Mar. 2013.
190.T Nakayama, Hirotsugu Kurobe, H Sugasawa, Hajime Kinoshita, M Higashida, Y Matsuoka, Y Yoshida, Y Hirata, M Sakata, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa and Shuhei Tomita :
Macrophage-specific HIF-1a-deficient Mice Suppress Vascular Remodeling.,
第77回 日本循環器学会学術集会, Mar. 2013.
191.中山 泰介, Shuhei Tomita, Hirotsugu Kurobe, 菅澤 典子, Hajime Kinoshita, Mikio Sugano, Tamotsu Kanbara, Eiki Fujimoto, Takashi Kitaichi, Toshiaki Tamaki, Masataka Sata and Tetsuya Kitagawa :
小口径グラフト開存を目的とするマクロファージHIFと極性の動脈リモデリング基礎研究,
第43回日本心臓血管外科学会学術総会, Feb. 2013.
192.Yuki Izawa-Ishizawa, Keisuke Ishizawa, Noriko Yamano, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは血管内皮細胞障害を伴う糖尿病性腎症の進展を抑制する,
第42回日本心脈管作動物質学会, Feb. 2013.
193.田島 壮一郎, Yasumasa Ikeda, Hideaki Enomoto, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
鉄制限食によってdb/dbマウスの糖尿病性腎症進展は抑制される,
第42回日本心脈管作動物質学会, Feb. 2013.
194.Sakiko Doi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Yusuke Kohara, Tomoko Nagao, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
無機リン刺激による血管平滑筋細胞石灰化におけるRho-kinaseの関与,
第42回日本心脈管作動物質学会, Feb. 2013.
195.Yoshitaka Kihira, Shuhei Tomita, Mariko Miyake, Yoji Hoshina, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
脂肪細胞特異的低酸素誘導因子欠損マウスに観察される耐糖能の改善にはglucagon-like peptide-1が関与する,
第42回日本心脈管作動物質学会, Feb. 2013.
196.Shuhei Tomita, Yoshitaka Kihira, Masaki Imanishi and Toshiaki Tamaki :
疾患に伴う血管リモデリング進展過程における低酸素応答性転写制御因子HIFの役割,
第85回日本生化学会大会, Dec. 2012.
197.Keisuke Ishizawa, Masaki Imanishi, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Angiotensin II慢性投与はhypoxia-inducible factor-1αを介して血管リモデリングを惹起する,
第33回日本臨床薬理学会学術総会, Dec. 2012.
198.Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に寄与するメカニズムの解析,
第22回日本循環薬理学会, Nov. 2012.
199.Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄吸収機構におけるAngiotensinⅡの効果の検討,
第122回日本薬理学会近畿部会, Nov. 2012.
200.Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
Nifedipine 光分解産物であるnitrosonifedipine は糖尿病性腎症進展を抑制する,
第51回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Nov. 2012.
201.中山 泰介, Shuhei Tomita, Hirotsugu Kurobe, 菅澤 典子, Hajime Kinoshita, Mikio Sugano, Tamotsu Kanbara, Eiki Fujimoto, Takashi Kitaichi, Toshiaki Tamaki, Masataka Sata, Yousuke Takahama and Tetsuya Kitagawa :
小口径グラフト開存性改善を目的とする血管リモデリングにおけるマクロファージの基礎研究,
第65回日本胸部外科学会定期学術集会, Oct. 2012.
202.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
血管平滑筋細胞におけるHIF-1αのangiotensinⅡ誘発血管リモデリング形成およびAT1受容体発現への関与;平滑筋特異的HIF-1α遺伝子欠損マウスを用いた検討 The Role of HIF-1α in angiotensin Ⅱ-induced Vascular Remodeling and AT1 Receptor Expression in Vascular Smooth Muscle Cells,
第35回日本高血圧学会総会, Sep. 2012.
203.Asami Nuno, Keisuke Ishizawa, Shoko Fujii, 櫻田 巧, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病性腎症進展に対するニトロソニフェジピンの抑制作用,
次世代を担う創薬・医療薬理シンポジウム2012, Sep. 2012.
204.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
AngiotensinⅡ誘発血管リモデリングにおける血管平滑筋細胞内HIFシグナルの解析,
次世代を担う創薬・医療薬理シンポジウム2012, Sep. 2012.
205.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Yuya Horinouchi, 櫻田 巧, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
十二指腸からの鉄吸収に対するAngiotensinⅡの影響,
第36回日本鉄バイオサイエンス学会学術集会, Sep. 2012.
206.Yusaku Maeda, Shuhei Tomita, Masaki Murakami, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する,
第121回日本薬理学会近畿部会, Jun. 2012.
207.Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
平滑筋特異的hypoxia-inducible factor-1α欠損がangiotensin II誘発血管リモデリング形成に及ぼす影響,
第121回日本薬理学会近畿部会, Jun. 2012.
208.Yasumasa Ikeda, 田島 壮一郎, Koichiro Tsuchiya and Toshiaki Tamaki :
肥満進展における鉄と酸化ストレス,
第65回日本酸化ストレス学会学術集会 シンポジウム「金属と酸化ストレスの関係を探る:基礎から臨床研究へ」, Jun. 2012.
209.Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yuki Izawa-Ishizawa, Licht Miyamoto, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine はangiotensin II 誘発のマウス血管リモデリングを改善する,
第65回日本酸化ストレス学会学術集会, Jun. 2012.
210.Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病モデルマウスにおいてニトロソニフェジピンは腎症の進展を抑制する,
第55回日本腎臓学会学術総会, Jun. 2012.
211.中山 泰介, Hirotsugu Kurobe, 菅澤 典子, 東田 真由子, 吉田 恭史, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa and 冨田 修平 :
小口径グラフト開存性改善を目的とするマクロファージHIF制御に関しての基礎研究,
第42回日本心臓血管外科学会学術総会, Apr. 2012.
212.Mariko Miyake, Yoshitaka Kihira, Manami Hirata, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
脂肪細胞における低酸素誘導因子1a欠損は高脂肪食負荷による耐糖能異常の発現を抑制する,
日本薬学会第132年会, Mar. 2012.
213.Shuichi Hamano, Yoko Kagawa, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
セスキテルペンラクトン誘導体の鉄依存ラジカル生成機構の検討,
日本薬学会大132年会, Mar. 2012.
214.Asami Nuno, Keisuke Ishizawa, 藤井 聖子, Yuki Izawa-Ishizawa, Masaki Imanishi, Takumi Sakurada, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
2型糖尿病性腎症に対するニトロソニフェジピンの効果,
日本薬学会第132年会, Mar. 2012.
215.Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Bovine Lactoferin Promotes Angiogenesis Via Akt-eNOS Dependent Pathway in Vascular Endothelial Cells,
第76回日本循環器学会学術集会, Mar. 2012.
216.Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Mayuko Higashida, Yuuki Matsuoka, Mitsuru Takaku, Yasushi Yoshida, Yoichiro Hirata, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa and Shuhei Tomita :
Role of Hypoxia-Inducible Factor1-alpha in Macrophage as an Aggravation Regulator in Development of Vascular Remodeling.,
第76回 日本循環器学会学術集会, Mar. 2012.
217.Hideaki Enomoto, Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Protective effect of dietary iron restriction on diabetic nephropathy,
第85回日本薬理学会年会, Mar. 2012.
218.Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Accumulated iron storage in high fat diet-induced obese and diabetic mice,
第85回日本薬理学会年会, Mar. 2012.
219.Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine prevents the progression of diabetic nephropathy in type 2 diabetic mice,
第85回日本薬理学会年会, Mar. 2012.
220.Shuhei Tomita, Mitsuru Takaku, Noriko Yamano, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Preoperative stabilization of HIF-1 by systemic introduction of dimethyloxalylglycine (DMOG), improves skin flap survival,
第85回日本薬理学会年会, Mar. 2012.
221.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
The inhibitory effects of smooth muscle cell-specific hypoxia-inducible factor-1a deficiency on angiotensin 2-induced vascular remodeling in mice,
第85回日本薬理学会年会, Mar. 2012.
222.Manami Hirata, Yoshitaka Kihira, Mariko Miyake, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
High fat diet-induced inflammation in adipose tissues is reduced in adipocyte-specific hypoxia-inducible factor-1a knockout mice,
第85回日本薬理学会年会, Mar. 2012.
223.Keisuke Ishizawa, Shoko Fujii, Asami Nuno, Yuki Izawa-Ishizawa, Masaki Imanishi, Takumi Sakurada, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineは2型糖尿病モデルマウスにおける腎症進展を抑制する,
第41回心脈管作動物質学会, Feb. 2012.
224.Yoshitaka Kihira, Mariko Miyake, Manami Hirata, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
肥満に伴う耐糖能異常の発現に対する脂肪細胞の低酸素誘導因子の役割,
第41回心脈管作動物質学会, Feb. 2012.
225.Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
The alternation of iron metabolism in high fat diet-induced obese and diabetic mice,
第34回日本分子生物学会年会, Dec. 2011.
226.Yasumasa Ikeda, Hideaki Enomoto, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病腎症進展における鉄除去の効果,
腎と高血圧update, Dec. 2011.
227.Mitsuru Takaku, Shuhei Tomita, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Hideki Nakanishi and Toshiaki Tamaki :
PHD阻害剤の虚血皮弁生存拡大に対する効果,
第21回日本循環薬理学会, Dec. 2011.
228.Jumpei Taniguchi, Keisuke Ishizawa, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Kazuo Minakuchi, Toshiaki Tamaki and Shuhei Tomita :
血管平滑筋細胞のhypoxia-inducible factor-1αはangiotensinⅡ誘発血管リモデリングの形成に関与する,
第50回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2011.
229.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Jumpei Taniguchi, Shoko Fujii, Asami Nuno, Yuta Suzuki, Licht Miyamoto, Yoshitaka Kihira, Koichiro Tsuchiya, Kazuyoshi Kawazoe, Kazuo Minakuchi and Toshiaki Tamaki :
マウス血管リモデリングに対するnitrosonifedipineの抑制効果,
第50回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2011.
230.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
AngiotensinⅡ誘発性血管リモデリングは平滑筋特異的HIF-1α遺伝子欠損により抑制される,
第34回日本高血圧学会総会, Oct. 2011.
231.高久 暢, Shuhei Tomita, 木山 明, Hirotsugu Kurobe, Toshiaki Tamaki, Ichiro Hashimoto and Hideki Nakanishi :
虚血皮弁生存に対するPHD阻害剤の効果,
第20回日本形成外科学会基礎学術集会, Oct. 2011.
232.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Noriko Yamano, Yuya Horinouchi, Takumi Sakurada, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
肥満の脂肪組織における鉄の役割,
第35回日本鉄バイオサイエンス学会学術集会, Sep. 2011.
233.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Jumpei Taniguchi, Shoko Fujii, Asami Nuno, Yuta Suzuki, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineによるマウス血管リモデリング抑制機構の解明,
次世代を担う創薬・医療薬理シンポジウム2011, Aug. 2011.
234.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1a in vascular smooth muscle cells contributes to the development of angiotensin -induced vascular remodeling,
第43回日本動脈硬化学会 総会・学術集会, Jul. 2011.
235.Masashi Akaike, Koichiro Tsuchiya, Yoshiki Kashiwada, Yoshihisa Takaishi, Toshiaki Tamaki, Takashi Iwase, Masataka Sata, Ken-ichi Aihara, Sumiko Yoshida, Toshio Matsumoto, 佐藤 千穂, 西条 伴香 and Hiroaki Yanagawa :
生活習慣病関連リスクファクターに及ぼすスダチ果皮加工品の効果 ∼探索的臨床試験による検討∼,
第243回徳島医学会学術集会 公開シンポジウム, Jul. 2011.
236.Masashi Akaike, Koichiro Tsuchiya, Yoshiki Kashiwada, Yoshihisa Takaishi, Toshiaki Tamaki, Takashi Iwase, Masataka Sata, Ken-ichi Aihara, 吉田 守実子, Toshio Matsumoto, 佐藤 千穂, 西条 伴香 and Hiroaki Yanagawa :
生活習慣病関連リスクファクターに及ぼすスダチ果皮加工品の効果-探索的臨床試験による検討-,
第243回 徳島医学会学術集会, Jul. 2011.
237.Jumpei Taniguchi, Keisuke Ishizawa, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, 久次米 敏秀, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Kazuo Minakuchi, Toshiaki Tamaki and Shuhei Tomita :
動脈硬化におけるhypoxia-inducible factor-1αの新規治療標的分子としての可能性,
医療薬学フォーラム2011/第19回クリニカルファーマシーシンポジウム, Jul. 2011.
238.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
AngiotensisⅡ誘発血管リモデリングは血管平滑筋細胞のhypoxia-inducible factor-1αを介して形成される,
第119回日本薬理学会近畿部会, Jul. 2011.
239.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Yuya Horinouchi, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
ヒト腎糸球体血管内皮細胞において細胞内遊離鉄はangiotensin ⅡによるICAM-1の発現を増強する,
第54回日本腎臓学会学術集会, Jun. 2011.
240.高久 暢, Shuhei Tomita, Hirotsugu Kurobe, 牛山 明, Ichiro Hashimoto, Hideki Nakanishi and Toshiaki Tamaki :
虚血皮弁生存に対するPHD阻害剤の効果,
第32回日本炎症・再生医学会, Jun. 2011.
241.Yasumasa Ikeda, 田島 壮一郎, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄除去薬による糖尿病の病態改善効果の検討,
第84回日本内分泌学会学術集会, Apr. 2011.
242.Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, 佐藤 隆史, Masashi Akaike, Toshiaki Tamaki, 加藤 茂明 and Toshio Matsumoto :
心血管リモデリングにおける男性ホルモンの作用,
第84回日本内分泌学会学術集会 シンポジウム「心血管病を内分泌・代謝面から考察する」, Apr. 2011.
243.Yasumasa Ikeda, Soichiro Tajima, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron elimination ameliorated glucose tolerance through suppression of oxidative stress and inflammation on fat in diabetic mice,
第75回日本循環器学会総会・学術集会, Mar. 2011.
244.Yasumasa Ikeda, Ken-ichi Aihara, Masashi Akaike, Sumiko Yoshida, Takashi Iwase, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Masataka Sata, Toshio Matsumoto and Toshiaki Tamaki :
Heparin cofactor II enhances vascular endothelial cells function and angiogenesis,
第75回日本循環器学会総会・学術集会, Mar. 2011.
245.Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Soichiro Tajima, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
The alternation of iron transport-related genes in high fat diet-induced obese and diabetic mice,
第84回日本薬理学会年会, Mar. 2011.
246.Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
bFGF and insulin differentially regulate hypoxia-inducible factor-1 alpha in adipocytes,
第84回日本薬理学会年会, Mar. 2011.
247.Yayoi Fukuhara, Shuhei Tomita, Masahisa Urata, Yoshitaka Kihira, Mitsuru Takaku, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Role of HIF-1b in endothelial cells in monocrotaline-induced pulmonary hypertension,
第84回日本薬理学会年会, Mar. 2011.
248.Yasumasa Ikeda, Soichiro Tajima, Sumiko Yoshida, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Ken-ichi Aihara, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Deferoxamine, an iron chelator, promotes revascularization via endothelial cells activation,
第84回日本薬理学会年会, Mar. 2011.
249.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Erika Tominaga, Junpei Taniguchi, Shoko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine, a photodegrative metabolite of nifedipine, improves angiotensin -induced vascular remodeling,
第84回日本薬理学会年会, Mar. 2011.
250.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Angiotensin -induced vascular remodeling is surpressed in smooth muscle cell-specific hypoxia-inducible factor-1a deficient mice,
第84回日本薬理学会年会, Mar. 2011.
251.Masaki Imanishi, Keisuke Ishizawa, Takumi Sakurada, 富永 えりか, Yuya Horinouchi, Jumpei Taniguchi, Shoko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineによる血管リモデリング抑制効果の検討,
日本薬学会第131回年会, Mar. 2011.
252.Yuya Horinouchi, Koichiro Tsuchiya, 田島 壮一郎, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita, Kazuyoshi Kawazoe, Toshiaki Tamaki and Kazuo Minakuchi :
Nitrosonifedipine の細胞保護効果に関する検討,
日本薬学会第131年会, Mar. 2011.
253.Mitsuru Takaku, Shuhei Tomita, Takeshi Kotani, Ichiro Hashimoto, Hideki Nakanishi and Toshiaki Tamaki :
PHD阻害剤の虚血皮弁生存に対する効果,
第40回日本心脈管作動物質学会, Feb. 2011.
254.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Noriko Yamano, Yuya Horinouchi, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
鉄除去は脂肪肥大を抑制して糖尿病を改善する,
第40回日本心脈管作動物質学会, Feb. 2011.
255.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Yuya Horinouchi, 富永 えりか, Jumpei Taniguchi, Shoko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
AngiotensinⅡ誘発血管リモデリングに対するニトロソニフェジピンの抑制作用,
第40回日本心脈管作動物質学会, Feb. 2011.
256.Yasumasa Ikeda, 田島 壮一郎, Sumiko Yoshida, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Ken-ichi Aihara, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
マウス下肢虚血モデルにおいて鉄キレート剤Deferoxamineは酸化ストレスとアポトーシスを抑制する,
第40回日本心脈管作動物質学会, Feb. 2011.
257.Noriko Yamano, Yasumasa Ikeda, 田島 壮一郎, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
高脂肪食負荷肥満マウスにおける鉄吸収動態の検討,
第40回日本心脈管作動物質学会, Feb. 2011.
258.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Noriko Yamano, Yuya Horinouchi, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
鉄除去は脂肪肥大を抑制して糖尿病を改善する,
第40回日本心脈管作動物質学会, Feb. 2011.
259.Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Yuya Horinouchi, 富永 えりか, Jumpei Taniguchi, Shoko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
AngiotensinⅡ誘発血管リモデリングに対するニトロソニフェジピンの抑制作用,
第40回日本心脈管作動物質学会, Feb. 2011.
260.Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
AngiotensinⅡ誘発血管リモデリングにおけるhypoxia-inducible factor-1αの役割,
第40回日本心脈管作動物質学会, Feb. 2011.
261.Hirotsugu Kurobe, Shuhei Tomita, Tamotsu Kanbara, Tetsuya Kitagawa and Toshiaki Tamaki :
血管リモデリングに対してT細胞のHIF-1aは抑制的に機能する,
第18回 日本血管生物学学会, Dec. 2010.
262.Yasumasa Ikeda, 田島 壮一郎, Sumiko Yoshida, Noriko Yamano, Yoshitaka Kihira, Keisuke Ishizawa, Ken-ichi Aihara, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Deferoxamine, an iron chelator, enhances angiogenesis through Akt-eNOS-dependent pathway in endothelial cells,
第18回日本血管生物医学会学術集会, Dec. 2010.
263.Yuuko Imamura, Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
HIF-2/ARNT control hair differentiation by up-regulating p21Waf1/Cip1,
第33回日本分子生物学会年会, Dec. 2010.
264.Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
脂肪細胞における塩基性繊維芽細胞増殖因子による低酸素誘導因子誘導とそれを介した糖輸送担体発現誘導,
第118回日本薬理学会近畿部会, Nov. 2010.
265.富永 えりか, Keisuke Ishizawa, Masaki Imanishi, 櫻田 巧, 谷口 順平, 藤井 聖子, Yuya Horinouchi, Yoshitaka Kihira, Shinji Abe, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Toshiaki Tamaki and Kazuo Minakuchi :
アンジオテンシンII による血管リモデリングに対するニトロソニフェジピンの影響,
第49回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Nov. 2010.
266.田島 壮一郎, Yasumasa Ikeda, Yuya Horinouchi, Yoshitaka Kihira, Shuhei Tomita, Noriko Yamano, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄キレート剤 deferoxamine は内皮細胞活性化により血管新生を促進する,
第20回日本循環薬理学会, Nov. 2010.
267.Koichiro Tsuchiya, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita and Toshiaki Tamaki :
亜硝酸塩由来血中NO動態に与える経口鉄の影響,
第22回腎とフリーラジカル研究会, Oct. 2010.
268.Masaki Imanishi, Keisuke Ishizawa, 富永 えりか, 櫻田 巧, Yuya Horinouchi, 谷口 順平, 藤井 聖子, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II による血管平滑筋細胞の遊走および増殖に対するnifedipine代謝物の抑制作用とそのメカニズム,
第33回日本高血圧学会, Oct. 2010.
269.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Noriko Yamano, Yuya Horinouchi, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
2型糖尿病モデルマウスに対する鉄キレート剤による糖尿病改善効果の検討,
第34回日本鉄バイオサイエンス学会学術集会, Sep. 2010.
270.藤井 聖子, Keisuke Ishizawa, Masaki Imanishi, 富永 えりか, 桜田 巧, 谷口 順平, Yuya Horinouchi, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Toshiaki Tamaki and Koichiro Tsuchiya :
AngiotensinⅡ誘発血管リモデリングに対するnitrosonifedipineの抑制効果,
次世代を担う創薬・医療薬理シンポジウム2010, Sep. 2010.
271.Shuhei Tomita, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
動脈硬化に伴う血管リモデリングに対してT細胞のHIF-1 は抑制的に機能する.,
第31回日本炎症再生医学会, Aug. 2010.
272.Masaki Imanishi, Keisuke Ishizawa, 富永 えりか, Yuya Horinouchi, 谷口 順平, 藤井 聖子, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nifedipine代謝物によるangiotensin II 誘発血管平滑筋細胞遊走及び増殖に対する抑制作用,
第117回日本薬理学会近畿部会, Jul. 2010.
273.Keisuke Ishizawa, Masaki Imanishi, Erika Tminaga, Yuya Horinouchi, Takumi Sakurada, Zyunpei Taniguchi, Seiko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Toshiaki Tamaki and Koichiro Tsuchiya :
Nifedipine代謝物はangiotensinⅡによる血管平滑筋細胞遊走および増殖を抑制する,
第63回日本酸化ストレス学会, Jun. 2010.
274.Yasumasa Ikeda, Koichiro Tsuchiya, 田島 壮一郎, Yuya Horinouchi, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Yoshihisa Takaishi and Toshiaki Tamaki :
The effect of SUDACHI peel, a specialty of Tokushima, as anti-metabolic syndrome,
第83回日本薬理学会年会 シンポジウム「 肥満の栄養ゲノミクスと薬理ゲノミクス」, Mar. 2010.
275.Keisuke Ishizawa, Masanori Yoshizumi, Dortsuren Naruantungalag, 今村 優子, Yasumasa Ikeda, Junji Terao, Koichiro Tsuchiya and Toshiaki Tamaki :
ケルセチンの生体内代謝と動脈硬化予防効果,
第83回 日本薬理学会年会シンポジウム「健康食品の薬理学」, Mar. 2010.
276.Shuhei Tomita, Yoshitaka Kihira, Yayoi Fukuhara, 桜田 巧, 今西 正樹 and Toshiaki Tamaki :
病態に観られる低酸素応答の意義-血管リモデリングにおけるT細胞のHIF-1の役割-,
第83回 日本薬理学会年会シンポジウム「病態における低酸素応答機構の解明と治療への応用」, Mar. 2010.
277.田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Yuya Horinouchi, 櫻田 巧, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
KK-Ay マウスにおける鉄キレート剤Deferoxamineによる糖尿病病態改善効果の検討,
第83回 日本薬理学会, Mar. 2010.
278.Hirotsugu Kurobe, 浦田 将久, Yayoi Fukuhara, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Yousuke Takahama, Toshiaki Tamaki, Toshio Matsumoto, Shuhei Tomita and Tetsuya Kitagawa :
血管リモデリング時の転写因子HIF-1αの役割 (第110回日本外科学会定期学術集会),
Journal of Japan Surgical Society, Vol.111, No.2, 701, Mar. 2010.
(CiNii: 110007718434)
279.Yayoi Fukuhara, Shuhei Tomita, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Masanori Yoshizumi and Toshiaki Tamaki :
T細胞のHIF-1aは,動脈硬化に伴う血管リモデリングを抑制的に制御する,
第39回日本心脈管作動物質学会, Feb. 2010.
280.Yasumasa Ikeda, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita and Toshiaki Tamaki :
鉄キレート剤 Deferoxamine の血管新生左葉―マウス下肢虚血モデルにおける検討―,
第39回日本心脈管作動物質学会, Feb. 2010.
281.富永 えりか, Keisuke Ishizawa, 櫻田 巧, 今西 正樹, 谷口 順平, Kazuyoshi Kawazoe, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
Angiotensin IIによる血管平滑筋細胞遊走に対するnifedipine代謝物の影響,
第30回日本臨床薬理学会年会, Dec. 2009.
282.富永 えりか, Keisuke Ishizawa, 櫻田 巧, 今西 正樹, 谷口 順平, 山﨑 有希子, Yoshitaka Kihira, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
ニフェジピン代謝物はアンジオテンシンⅡ誘発血管平滑筋細胞遊走を抑制する,
第48回 日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Nov. 2009.
283.山﨑 有希子, Keisuke Ishizawa, 富永 えりか, 谷口 順平, 櫻田 巧, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Toshiaki Tamaki and Kazuo Minakuchi :
アンジオテンシンⅡによる血管平滑筋細胞遊走・増殖における細胞内鉄の関与,
第48回 日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Nov. 2009.
284.福原 弥生, Shuhei Tomita, 浦田 将久, Yoshitaka Kihira, 池田 康将, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
モノクロタリン誘導肺高血圧症モデルマウスにおける 血管内皮細胞の低酸素応答因子(HIF-1b)の役割,
第116回 日本薬理学会近畿部会, Jun. 2009.
285.Yoshitaka Kihira, 御園生 裕明, Keisuke Ishizawa, 池田 康将, Shuhei Tomita and Toshiaki Tamaki :
電位依存性Kチャネル Kv2.1とKv2.2の相互作用,
第115回 日本薬理学会近畿部会, Jun. 2009.
286.田島 壮一郎, Koichiro Tsuchiya, 濱本 磨以, Yuya Horinouchi, Shuhei Tomita, Keisuke Ishizawa, Kazuyoshi Kawazoe, Toshiaki Tamaki and Kazuo Minakuchi :
Angiotensin IIによるヒト腎糸球体血管内皮細胞(HGEC)内における鉄動態の検討,
日本薬学会129年会, Mar. 2009.
287.廣永 有沙, Keisuke Ishizawa, 山崎 有希子, 野瀬 文乃, Kazuyoshi Kawazoe, Toshiaki Tamaki and Kazuo Minakuchi :
オルメサルタンはPDGF誘導メサンギウム細胞遊走をAT1受容体非依存的に抑制する,
第47回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, 189, Nov. 2008.
288.渡邊 政博, Takenori Yamamoto, 角幡 玲, 岡田 直人, 梶本 和昭, Naoshi Yamazaki, Masatoshi Kataoka, Yoshinobu Baba, Toshiaki Tamaki and Yasuo Shinohara :
褐色脂肪組織の機能亢進に関与する新規因子の探索,
第6回ファーマ・バイオフォーラム 2007, Dec. 2007.
289.田岡 千明, Koichiro Tsuchiya, 神谷 昌樹, Hisao Nemoto, Keisuke Ishizawa, Kunihisa Yamaguchi, Yoshiharu Takiguchi and Toshiaki Tamaki :
水溶性Fenofibrate製剤の作成と中性脂肪低下作用の検討,
第111回 日本薬理学会近畿部会, 81, Jun. 2007.
290.松村 敏彦, 宮本 由加里, 黒川 ふみ, Shinji Abe, 榊原 啓之, Keisuke Ishizawa, Koichiro Tsuchiya, 清水 寛, Junji Terao, Toshiaki Tamaki, Kazuyoshi Kawazoe and Kazuo Minakuchi :
ラット強制水泳試験における漢方薬の抗うつ作用の検討,
第45回日本薬学会・日本病院薬剤師会中国四国支部学術大会, 125, Oct. 2006.
291.平 広範, Keisuke Ishizawa, 廣永 有沙, Kazuyoshi Kawazoe, Toshiaki Tamaki and Kazuo Minakuchi :
血管内皮細胞障害におけるアンジオテンシンII受容体拮抗薬の保護効果,
第45回日本薬学会・日本病院薬剤師会中国四国支部学術大会, 102, Oct. 2006.
292.Kazuyoshi Kawazoe, 松村 敏彦, 黒川 ふみ, 榊原 啓之, Keisuke Ishizawa, Koichiro Tsuchiya, 清水 寛, Junji Terao, Toshiaki Tamaki and Kazuo Minakuchi :
ラット強制水泳試験による漢方薬の抗うつ作用評価,
第109回日本薬理学会近畿部会, 30, Jun. 2006.
293.Hirotsugu Kurobe, Yuki Izawa, Yayoi Fukumura, Tamotsu Kanbara, Atsushi Kurushima, Ken-ichi Aihara, Masashi Akaike, Masashi Kano, Takashi Kitaichi, Yutaka Masuda, Hiroyuki Azuma, Toshiaki Tamaki, Toshio Matsumoto, Tetsuya Kitagawa, Shuhei Tomita and Masanori Yoshizumi :
HIF-ARNT transcriptional system in T cells has a pivotal role in vascular in flammation and remodeling.,
第70回日本循環器学会学術総会, Mar. 2006.
294.Hirotsugu Kurobe, Shuhei Tomita, Yuki Izawa, 福原 弥生, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Tetsuya Kitagawa, Toshio Matsumoto, Masanori Yoshizumi and Toshiaki Tamaki :
T細胞特異的HIF1αKOマイスではカフモデルにて血管リモデリングが促進される,
第15回日本循環薬理学会, Nov. 2005.
295.Hiroki Moriguchi, Takafumi Katayama, Toshiaki Tamaki, Yoshiyasu Terashima and 山本 誠 :
「Tutorial Hybrid System」の開発と運用,
医療情報学22回連合大会論文集, 476-477, Nov. 2002.

Et cetera, Workshop:

1.池田 裕美子, 斎藤 尚子, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
ケルセチンによる血管保護効果の検討,
西日本医学生学術フォーラム(第5回医学研究学生フォーラム), Dec. 2016.
2.Yoshito Zamami, Masaki Imanishi, Kenshi Takechi, Yuya Horinouchi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いた新規循環器治療薬の探索研究,
第23回大阪市大フォーラム, Aug. 2016.
3.津田 勝範, Licht Miyamoto, 森本 悠里, Shuichi Hamano, Keisuke Ishizawa, 木平 考高, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
鉄過剰ストレスに対するニトロソニフェジピン(NO-NIF)の抗酸化メカニズム検討,
徳島医学会, Aug. 2015.

Report:

1.Satoshi Kiriyama, Takao Hanabusa, Hideo Araki, Koichi Nakamura, Shingo Kuroiwa, Shoichiro Fujisawa, Masanobu Haraguchi, Toshiaki Tamaki, Tatsuji Haneji, Yoshihisa Takaishi, Seishi Kitayama, Makoto Ohashi and Tetsushi Ueta :
特色ある大学教育支援プログラム「進取の気風」を育む創造性教育の推進 平成17年度 報告書,
特色ある大学教育支援プログラム「進取の気風」を育む創造性教育の推進 平成17年度 報告書, Tokushima, Mar. 2006.
2.Masanori Yoshizumi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
インスリン抵抗性に対するロサルタンおよびロサルタンと運動の併用による効果-モデルラットを用いたin vivoでの検討-,
第17回 健康医科学 研究助成論文集, No.17, 124-134, Tokyo, Mar. 2002.

Patent:

1.Toshiaki Tamaki, Yasumasa Ikeda and Koichiro Tsuchiya : マクロファージの浸潤抑制によるインスリン抵抗性改善剤, (2011), 2011-174001 (2011).

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • Role of ADAM17 in the progression of chronic kidney disease (Project/Area Number: 17K10144 )
  • Physiological role of dietary nitrite (Project/Area Number: 15H02898 )
  • Activation mechanisms of AMPK by nitrite (Project/Area Number: 25460332 )
  • Mechanism of hypoxia-induced transformation in endothelial cells (Project/Area Number: 24590381 )
  • The renal protective effects of nitrite salts in diabetic nephropathy model rats. (Project/Area Number: 22590241 )
  • Mechanisms of hypoxia-induced transformation in endothelial cells (Project/Area Number: 21590335 )
  • CharaGterization of the evoked inflammation via hypoxic response in endothelial cells (Project/Area Number: 19590281 )
  • Elucidation of the formation pathways of nitric oxide involved in the reduction of orally-ingested nitrite in vivo (Project/Area Number: 18590235 )
  • communication analysis of university educational reform : on-the-spot examination (Project/Area Number: 18330105 )
  • Physiological and pathophysiological role of nitrite-derived nitric oxide formation (Project/Area Number: 17390066 )
  • Nitrite-derived nitric oxide formation and its pathophysiological effects following ischemia-reperfusion injury in kidney (Project/Area Number: 16590196 )
  • Investigation of the pathophysiological significance of big mitogen-activated protein kinase 1 in diabetic microangiopathy for the development of molecular-targeted drugs (Project/Area Number: 16590195 )
  • Ethnomethodology on Medical Education : Interactional analysis of OSCE and Medical Interview Test (Project/Area Number: 15330100 )
  • Investigation of the pathophysiological significance of big mitogen-acivated protein kinase 1 in diabetic nephropathy for the development of molecular-targeted drugs (Project/Area Number: 14570078 )
  • Mechanism of the production of reactive nitrogen species during renal ischemic-reperfusion insult (Project/Area Number: 13670087 )
  • Pathophysiological role of ET-1(1-31) on the inflammatory diseases. (Project/Area Number: 12557008 )
  • Experimental studies on circulatory disturbances in the spinal cord after traumatic spinal cord injury. (Project/Area Number: 11470311 )
  • Role of newly discovered endothelin-1(1-31) on renal injury (Project/Area Number: 10670085 )
  • Control of renal hemodynamics -with special reference to tubulo-glomerular feedback- (Project/Area Number: 06454161 )
  • Development of microdialysis probe for the kidney (Project/Area Number: 04557010 )
  • Control of renal hemodynamics- with special reference on isolated afferent arteriole (Project/Area Number: 03454145 )
  • Regulatory mechanisms of renal hemodynamics at the basis of arteriolar level. (Project/Area Number: 62570089 )
  • Search by Researcher Number (80179879)